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‘Just look down there’ said Denny.
‘That seemingly endless convoy,
trailing along the dried up valley below,
look for all the world like ants.’
‘They ARE ants’ said his companion Minnie,
‘And so are we’.
And it was true.
They were both ants,
perched on the edge of a clod of earth
no more than six inches high.
‘Oh’, sighed Denny sadly,
‘I forgot’.
Robert Wyatt – Comicopera
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Summary
All life known consists of cells. Every cell contains DNA. DNA is just a code. A
code existent of four simple letters A, T, G and C. But the sequence composed of
these letters contains nearly all information needed to form a complete organism
as complex as a human being out of a single fertilized egg cell. And every single
cell — up to a few exceptions — of one organism contains exactly the same DNA
sequence as the fertilized egg, the genetic information. This genetic information
belonging to a cell or organism is called a genome. This code is executed by the
genes whereas a gene may contain structural, signalling or regulatory information.
Our comprehension of the genetic machinery regulating the expression of thou-
sands of different genes controlling cell differentiation or responding to various
external signals is still highly incomplete. Furthermore, recently discovered reg-
ulatory mechanisms like those mediated by microRNAs expand our knowledge
but also add an additional layer of complexity. Since all genes are primarily
transcribed into RNA, the genetic activity of gene differential expression can be
estimated by measuring the RNA expression. Several techniques to measure large
scale gene expression on the basis of RNA have been developed. In this work,
data generated with the microarray technology, one of the most commonly used
methods, were analyzed towards extracting novel biological regulatory structures.
In the following several aspects on the analysis of these large gene expression
data will be discussed. Since this is nowadays a common task, a lot has been writ-
ten about various methods in all its particulars, but often from a more technical
or statistical point of view. However, the aim of a biologist planning and carrying
out a microarray experiment lies on the acquisition of novel biological findings.
In fact, there is still a gap between the experimentalists and the methods devel-
oping community. The experimentalists are often not too familiar with the latest
fancy method based on modern statistics as it is used in e.g. information the-
ory whereas the developing community normally does not deal extensively with
current biological questions. Therefore, the author of this work tries to give an
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additional view on the field of microarray analysis and the applicability of diverse
methods. Hence, the focus is to discuss commonly used methods towards their
usage, the underlying biological assumptions and the possible interpretations,
pros and cons. Furthermore, beyond ordinary differential gene expression analy-
ses, this work also concentrates on an unbiased search for hidden information in
gene expression patterns.
In the first section of chapter 1, a general overview about the main biological
principles is given. The term transcriptome and its composition of several RNA
types will be introduced. Furthermore the mechanism controlling gene expression
will be presented. The chapter further explains the basic principles of microarray
technology and also discusses the advantages and limitations of this method.
Finally, by means of two different biological models, commonly used and a few
more specialized and less popular analysis methods will be presented. In doing
so, less emphasis is given on a complete and detailed mathematical description,
but more on a general applicability and the biological outcome of these tools.
Chapter 2 extensively discusses the usage of a blind source separation tech-
nique, independent component analysis (ICA), on a two class microarray dataset.
Monocytes extracted from human donors were differentiated into macrophages
using M-CSF (Macrophage Colony-Stimulating Factor). By applying ICA to the
data, so called expression modes or sub-modes could be extracted. According to
referring biological annotations, these sub-modes were then combined to meta
modes and elaborately discussed. In this way, several known biological signalling
pathways as well as regulatory mechanism involved in monocyte differentiation
could be reconstructed. Furthermore, a novel biological finding, the remaining
proliferative potential of macrophages could also be identified. The results of
this investigation were already published by the author [Lutter et al., 2008].
In chapter 3 again ICA was used, but in this case applied to time-dependent
microarray data, and results were compared to a very common analysis method,
hierarchical clustering. Time-dependent data was derived from human mono-
cytes infected with the intracellular pathogen F. tularensis. Using the clustering
approach, groups of genes referring to distinct timepoints were identified, and
a temporal behaviour of genetic immune response could be reconstructed. In
parallel, ICA was used to decompose the data into expression modes (analo-
gously to chapter 2). These modes were then mapped on the experimental time
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course. Compared to the clustering results, the ICA-based reconstructed immune
response was more detailed and temporal activity of distinct genes could be re-
solved more precisely. These findings were also published by the author [Lutter
et al., 2009].
In the following chapter 4, three different microarray datasets were used to
confirm a suggested regulatory mechanism. The observation that about 50%
of all microRNAs in humans and mice are intronic and therefore coupled with
the expression of protein coding genes, so-called host genes, allowed for the use
of established large-scale gene expression measurement techniques to approxi-
mate microRNA expression. Since a single microRNA can regulate up to dozens
of other protein-coding genes, the hypothesis that this expressional linkage in-
cludes an additional functional component was investigated. Using the ordinary
clustering algorithm ‘hierarchical clustering’ and an approach based on gene an-
notations, this hypothesis could be basically confirmed. The main results were
already outlined in a manuscript, which is currently under review.
Finally, in the last chapter, a short summary of the previous ones is given and
a conclusion is drawn. A short outlook about further developments within the
field of large gene expression data analysis is given and briefly discussed.
Taken together, the main contributions of this thesis are:
 This work provides an overview of the biology of gene expression and a
discussion of the major analysis methods with a focus on applications.
 Based on a two-class microarray experiment, the outcome of an independent
component analysis is investigated with respect to its biological relevance
[Lutter et al., 2008].
 By separating time dependent microarray data into independent compo-
nents, a method is presented that reconstructs a temporal regulatory net-
work with high biological impact [Lutter et al., 2009].
 A regulatory motif of conserved microRNA functionality is confirmed, al-
lowing for an expansion of the interpretation of gene expression data [manuscript
currently under review].
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Abbreviations
BSS blind source separation
C consensus model
Exp5 Exportin 5
fMRI functional magnetic resonance imaging
FP feature profile
GEM gene expression mode
GEP gene expression profile
GES gene expression signatures
GO gene ontology
GTF general transcription factor
IC independent component
ICA independent component analysis
LVS live vaccine strain
M-CSF mononuclear phagocyte colony-stimulating factor
MeSH Medical Subject Headings
miRNA microRNA
mRNA messenger RNA
NAT natural antisense transcript
ncRNA non-coding RNA
NMF non-negative matrix factorization
NO neurite outgrowth
NPC nuclear pore complex
PC principal component
PCA proinciple component analysis
pre-miRNA precursor miRNA
pre-mRNA precursor mRNA
pri-miRNA primary miRNA transcript
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PT pictar
RG response group
RISC RNA-induced silencing complex
RNPs RNA binding proteins
SAGE serial analysis of gene expression
SCD stem cell development
SG somitogenesis
SVM Support vector machine
TF transcription factor
TFBS transcription factor binding site
TS target scan
TSS transcriptional start site
UTR untranslated region
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1 Background
This work addresses the analysis of large scale gene expression data. In this chap-
ter we will outline the main biological mechanisms controlling gene expression,
introduce a widely used technique to measure gene activity and discuss several
commonly used analysis methods. First of all, however, since the perspective on
what a gene has, progressively being changing — and still changes — during the
last century, we will define the term gene as it is used in this work. According to
a recently proposed definition [Gerstein et al., 2007] a gene is a union of genomic
sequences encoding a coherent set of potentially overlapping functional products,
either RNA or protein. A brief overview of the principle steps in gene expression
and resulting gene products is given in figure 1.1.
1.1 Transcriptome
The transcriptome is defined as the collection of all gene transcripts in a cell
present at one time. This includes coding messenger RNA (mRNA) as well as
different types of non-coding RNA (ncRNA), with a broad variety of functions.
Thus, the transcriptome can be seen as a mirror of the genetic activity of a
cell. The transcription, as the initial cause of all cellular RNA (except viral
RNA etc), is a complex process regulated by several mechanisms. Compared
to the genome, the variety of the mRNA molecules even increases since each
gene may produce several types of mRNA by alternative splicing. Furthermore,
the lifespan of nearly all RNA molecules is limited and concerning mRNAs,
their degradation is controlled in a complex manner. All these processes change
their activity over time and directly or indirectly affect the composition of the
transcriptome, resulting in a highly dynamical and complex property of living
cells.
Regarding a living cell, the variety of different RNA types mirrors the multiple
functions RNA is responsible for. These functions cover transfer of information
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(mRNA, tRNA), structural and enzymatic formations (rRNA) as well as regu-
latory functions (ncRNA). In this work we will mainly concentrate on one part
of the transcriptome: the mRNA which can be extensively measured using mi-
croarray technology (see section 1.2). Since mRNA is the basis of translation, the
production of proteins, it is therefore an indirect indicator of effective gene ex-
pression. Here we will discuss the regulatory mechanisms controlling these diverse
parts of the transcriptome in more detail.
Figure 1.1: Several steps in gene expression. From one genomic region two different
primary transcripts are produced. Orange boxes denote protein coding sequences, blue
boxes denote for non-coding gene products. After splicing and/or processing five different
transcripts were produced, which finally lead to five different gene products. Proteins
are indicated by rounded rectangles. Main processing steps, which can be regulated are
also shown. For more details see text.
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1.1.1 RNA-Types
In general RNA can be classified into two main categories: coding RNA and
ncRNA. Whereas the former can be easily characterized since it contains protein
coding sequences, the latter has a multitude of functional roles and is not trans-
lated into proteins. The functional roles of ncRNA are very diverse and, besides
others, ncRNAs are involved in splicing, translation and gene regulation. This
work is mainly based on the analysis of large scale mRNA expression profiles. In
the following, we will therefore mainly discuss two RNA types, mRNA as coding
RNA and microRNAs (miRNA) which have high impact on gene expression via
their influence on mRNAs. Further RNA types will be briefly described in section
1.1.1.3.
1.1.1.1 mRNA
The main proportion of the mammalian transcriptome is formed by the mRNA.
One mRNA always corresponds to a single gene which is defined ‘as the segment
of the DNA sequence corresponding to a single protein (or to a single catalytic
or structural RNA molecule for those genes that produce RNA but no protein)’
[Alberts et al., 2002]. The mRNA used to be primarily seen as the link between
a gene and corresponding protein. This perception becomes more and more out-
dated since recent research supposes that mRNA functionality is more complex
than expected (see chapter 4). However, in the simplest case, mRNA only trans-
ports genetic information from the DNA in the nucleus to a protein which is
produced in the cytoplasm. Therefore, a gene is transcribed by RNA polymerase
II into pre-mRNA and after several processing processes (see below) leaves the
nucleus as mature mRNA and is then translated into a peptide by ribosomes. The
mechanisms controlling transcription and translation will be discussed in sections
1.1.2 and 1.1.3. After transcription the eukaryotic precursor-mRNA (pre-mRNA)
is extensively processed. Processing includes modification of the 5’ and 3’ end as
well as ‘splicing’, a process to remove intron sequences from the primary tran-
script.
Shortly after the initiation of transcription a 5’-cap is added to the 5’-end of
the mRNA by a cap-synthesizing complex associated with the RNA polymerase.
The cap is exclusively added to mRNAs and helps to distinguish these from other
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types of RNA. Hence, it is essential for nuclear export and recognition by the
ribosome. Furthermore, it prevent mRNA from degradation by RNases.
With the end of transcription an enzyme called poly-A polymerase adds ap-
proximately 200 adenosine residues to the 3’-end of the transcript. The final
length of the poly-A tail is determined by so called poly-A-binding proteins, a
mechanism that is so far only poorly understood. However, the poly-A tail is im-
portant for termination of transcription, export from the nucleus, the translation
into protein and protection of the mRNA from degradation by exonucleases.
Protein coding sequences of eukaryotic genes are in many cases separated into
small pieces, the exons, which are interrupted by several stretches of non-coding
sequences, so-called introns. During RNA splicing, a process performed by the
spliceosome, the introns are removed from the pre-mRNA. This is a very complex
process catalyzed by a machinery consisting of five additional RNA molecules and
more than 50 proteins. This modular character of a gene subdivided in several
exons allows for multiple combinations of these, resulting in a variety of different
mRNA molecules from one gene. Therefore, one gene is able to produce a set
of different proteins, which are for instance in some case specific for different
tissues [Holmberg et al., 2000]. A further interesting attribute of splicing is the
generation of individual miRNAs located in intronic sequences and transcribed
together with the pre-mRNA [Baskerville and Bartel, 2005]. The functions of
these miRNAs will be discussed in the next sections.
1.1.1.2 MicroRNA
MicroRNAs are short, about 22nt long, noncoding RNA molecules. Since their
discovery [Lee et al., 1993; Wightman et al., 1993] hundreds of miRNAs have
been discovered in plants and animals [Lagos-Quintana et al., 2001; Reinhart
et al., 2002; Lim et al., 2003]. After identification of their posttranscriptional
gene repression by base-pairing [Hutva´gner et al., 2001; Zeng and Cullen, 2003],
the abundant regulatory impact on gene expression emerged. Primary expres-
sion of mammalian mRNAs is mainly subdivided into two types. One way of
miRNA transcription is the transcription of miRNA genes that is controlled by
an independent promoter. These genes may lead towards poly-cistronic miRNA
transcripts with several co-expressed miRNAs [Lagos-Quintana et al., 2001; Lau
et al., 2001]. The co-expression of miRNAs seems to be linked with a common
20
function [Ambros, 2008]. The second way how a miRNA can be expressed is co-
expression with protein coding genes. About half of the mammalian miRNAs, in
human more than 50 %, appear to be co-expressed. These so-called intronic miR-
NAs are mainly located within the intron of the host genes, but miRNAs located
in exons as well as in 3’UTRs (untranslated regions) have also been discovered
[Lagos-Quintana et al., 2003; Rodriguez et al., 2004]. The conserved linkage of
expression between a protein coding gene and a miRNA strongly suggests that
there is also a functional relationship between host gene and miRNA. This could
be already shown for two individual miRNAs [Barik, 2008; Zhu et al., 2009].
A general functional relationship between host genes and their intronic miR-
NAs is extensively analyzed in chapter 4. However, most miRNAs are therefore
transcribed by RNA polymerase II, aside from some human miRNAs within alu-
repetitive elements, which can be transcribed by RNA polymerase III [Borchert
et al., 2006].
Maturation of miRNAs occurs through sequential processing steps. After tran-
scription canonical primary transcripts (pri-miRNAs) forms ∼70nt duplex like
hairpin-loops, which are cleaved in the nucleus by the RNase III enzyme Drosha.
In case of intronic miRNAs Drosha cleavage was shown to occur closely related
to the splicing process [Kim and Kim, 2007]. A special type of intronic miRNAs,
so called mirtrons were processed within an alternative pathway. These, also
intronic miRNAs, mimic hairpin structures of pre-miRNAs and bypass Drosha-
mediated cleavage to enter the miRNA pathway during splicing [Ruby et al.,
2007; Berezikov et al., 2007].
After export of the miRNA precursor (pre-miRNA) from the nucleus to the
cytoplasm another RNase III enzyme called Dicer mediates the next processing
step [Zamore et al., 2000; Ketting et al., 2001]. Dicer recognizes the double-
stranded portion of the pre-miRNA, cuts both strands of the duplex and thereby
removes the loop of the hairpin. According to the current model, the end of the
pre-miRNA defining the mature ∼22nt long miRNA is defined during nuclear
cleaving by Drosha [Lee et al., 2003]. The so-called guide-strand is then selected
by the Argonaut proteins and integrated into a ribonucleoprotein complex, known
as the RNA-induced silencing complex (RISC). The active RISC, the complex
bound to single-stranded miRNA, identifies target mRNA sequences based on
complementarity and controls their expression by either degradation or inhibition
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Figure 1.2: Schematic representation of the miRNA pathway. The primary miRNA
transcript (pri-miRNA) derived from a miRNA gene or an intron of a protein coding
gene is cleaved by the RNase III enzyme Drosha. After this cleavage, the precursor
miRNA (pre-miRNA), which may also be derived from so-called mirtrons is exported
into the cytoplasm. Dicer, another RNase III enzyme cleaves the pre-miRNA and the so-
called guide strand is incorporated into RISC. For a detailed explanation of the miRNA
pathway see text.
of translation. A schematic representation of the miRNA pathway is shown in
figure 1.2. This regulatory mechanism will be discussed in more detail in section
1.1.3.
1.1.1.3 Further non-coding types of RNA
Besides mRNAs and the already discussed noncoding miRNAs several other
ncRNA types are known. They form a diverse group of RNAs including function-
ally well-understood RNAs such as tRNA and rRNA, as well RNA types with
more or less obscure functionality, like small nuclear RNAs (snRNAs), piwi-
interacting RNA (piRNA), and long non-coding RNAs (long ncRNAs). Since the
impact on gene expression of most of these RNA types is marginal, unknown or
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RNA type Function
miRNA
(microRNA)
(∼22nt length) gene regulation by translational
repressing or mRNA degradation
siRNA
(small interfering RNA)
(20-25nt length) RNA interference; taming of
transposons and combating viral infections
piRNA
(Piwi-associated RNA)
(25-30nt length) essential in the development
of germ cells
rRNA
(ribosomal RNA)
mediates decoding of mRNA to amino-acid se-
quences of protein
tRNA
(transfer RNA)
transfers a specific amino acid to a growing
polypeptide during translation
snRNA
(small nuclear RNA)
involved in several processes in the nucleus, like
splicing and maintenance of the telomeres
long-ncRNA
(longer non-coding RNA)
participate in various cellular processes, includ-
ing splicing and ribosome biogenesis
Table 1.1: Members of the ncRNA family, abbreviations and function.
not measureable by the methods discussed in this work, only a short overview of
known members of the eukaryotic ncRNA family can be found in table 1.1.
1.1.2 Control of Transcription
The process of copying one DNA strand into a complementary RNA strand
by the RNA polymerase enzyme is generally called transcription. In eukaryotes,
several RNA polymerases synthesize the different types of RNA. mRNA and most
miRNAs for instance are synthesized by RNA polymerase II. The whole process
can be subdivided into three main stages: initiation, elongation and termination.
Initiation summarizes the binding of the RNA polymerase enzyme to the DNA
by recognition of the promoter, separation of the duplex DNA structure and
initiation of the RNA synthesis process. During elongation, the RNA polymeraze
traverses the template strand from 3’ to 5’ generating the RNA copy of the coding
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strand in 5’ to 3’ direction. Elongation continues until the RNA polymerase
encounters a termination signal encoded on the DNA. The transcription stops
and the polymerase releases the DNA template as well as the newly synthesized
RNA.
Transcription is the first step in gene expression and is controlled by several
complex mechanisms. In the following, the main mechanisms will be briefly dis-
cussed.
1.1.2.1 Chromatin structure
In eukaryotic cells, the DNA is usually organized to a complex in the nucleus
called chromatin. The material of which chromosomes are made of. It is build of
DNA, histone and non-histone proteins, subdivided into nucleosomes. Transcrip-
tion of a gene is strongly dependent on the structure of the chromatin. Important
local alterations influencing transcription are histone modifications and nucleo-
some remodeling.
Histones can be modified through at least eight different ways [Kouzarides,
2007], which all have influence on transcriptional activity. For instance, histone
acetylation catalyzed by histone acetyltransferases alter the chromatin structure
in a way that allows for greater accessibility of the DNA. Hence DNA polymerase
and transcription factors have easier access to promoter regions. In contrast, his-
tone methylation inhibits translation through several different mechanisms [Sin-
gal and Ginder, 1999]. Since histone methylation patterns are heritable after cell
division, its role during differentiation processes is very important. Furthermore
histone methylation seems to have remarkable impact on the epigenetic memory
[Callinan and Feinberg, 2006]. Nucleosome remodeling is mediated by chromatin
remodeling complexes which also allows for greater accessibility of DNA packed
in chromatin to other proteins.
In general the chromatin structure controls gene expression on a basal level.
It is primarily accountable for accessibility of the DNA, thus protein coding as
well as regulatory sequences. It can further influence expression rates in various
ways, thereby forming the basic mechanisms of the gene expression regulatory
machinery.
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1.1.2.2 Transcription Factors
A protein that binds to the DNA or as a co-factor to the polymerase-DNA-
complex is termed a transcription factor (TF) if it is somehow required for initi-
ation or regulation of transcription in eukaryotes. There are general transcription
factors (GTF) that are required by the RNA polymerase II for DNA binding and
initiation of the RNA-synthesis. Not all of these GTFs actually bind to the DNA
but are part of the huge protein complex which directly interacts with the DNA
and the DNA polymerase.
Further DNA-binding proteins influence transcription in a variety of ways.
They can stabilize or block the binding of DNA polymerase, directly or indi-
rectly catalyze the acetylation or deacetylation of DNA (see 1.1.2.1) or recruit
co-activator or co-repressor proteins. TFs bind DNA at either promoter sequences
or cis-regulatory elements [Gill, 2001]. A promoter is defined as the nucleotide
sequence in the DNA to which RNA polymerase binds and starts transcription.
Promoters are found upstream of the transcriptional start site (TSS) and can
include regulatory elements several kilobases away from TSS. Besides the core
promoter, required to properly initiate transcription with the RNApol binding
site, it mainly consists of specific TF binding sites (TFBS). Cis-regulatory ele-
ments are short DNA sequences with specific TFBSs which can be located many
kilobases away from TSS. Together these sequences can be termed a ‘gene control
region’.
As the number of GTF is relatively small and similar for all polymerase II tran-
scribed genes, the amount and composition of additional regulatory proteins is
different for each gene. About 5-10% of all mammalian protein-coding sequences,
of estimated 20,000 to 25,000 human genes [Carninci and Hayashizaki, 2007], are
proposed to serve as regulators of gene transcription [Wilson et al., 2008]. Ex-
pression of each gene is controlled by a set of different TFs, whereas each of those
are in turn regulated by its own set of gene regulatory proteins. The resulting
exceedingly complex network controlling the expression of mammalian genes al-
lows for a diversity of spatial and temporal different transcriptional expression
patterns.
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1.1.2.3 non-codingRNA
In addition to transcriptional control mechanisms based on chromatin structure
or mediated by gene regulatory proteins, several ncRNAs have a functional role as
regulators of transcription [Carninci, 2008]. To date, there are several molecular
mechanisms identified, most of them only poorly understood. However, their
positive or negative influence on the transcription rate is shown [Morris et al.,
2008].
Among the various mechanisms identified by several studies are natural anti-
sense transcripts (NAT) and the specific binding to transcription factors and or
DNA sequences directly. Besides trans-NATs which mainly do not affect tran-
scription itself (e.g. miRNAs, see 1.1.3.3), cis-NATs for instance, may inhibit
transcription by histone modification within promoter regions [Osato et al., 2007].
Other ncRNAs can bind proteins involved in transcription, thus influencing their
activity [Storz, 2002]. Detailed explanations and further examples can be found in
a variety of recent articles [Barrandon et al., 2008; Carninci et al., 2008; Mattick
and Makunin, 2006].
1.1.3 Post-transcriptional control
Gene expression starts with transcription, which produces primary RNA tran-
scripts and is followed by several maturation steps. As shown above transcription
is controlled by various different mechanisms, while in principle each step can be
regulated independently. The single steps include processing of the primary tran-
scripts, splicing and export from the nucleus to the cytosol, where their cellular
localization can also be regulated. Furthermore, transcripts in the cytoplasm
may be selectively destabilized, activated, inactivated or degraded. Translation,
the process in which mRNA is finally translated into protein is also extensively
regulated.
All these regulatory mechanism that follow transcription and affect gene ex-
pression are referred to as post-transcriptional control. In this chapter we will
briefly discuss the main mechanisms of post-transcriptional control with strong
impact on the composition of the transcriptome and gene expression. Therefore,
we will basically focus on mRNA and miRNA.
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1.1.3.1 RNA transport and localization control
In eukaryotic cells synthesis and diverse pre-processing steps of RNA take place
in the nucleus. Several of the produced RNA types, including mRNA and pre-
miRNA, are exported to the cytoplasm where they serve as a template for protein
synthesis or influence the same in various ways. In general every RNA exported
from the nucleus must pass through the nuclear membrane via nuclear pore
complexes (NPC), but the distinct nuclear export pathways for different RNA
types vary [Cullen, 2003]. As far as the exact mechanisms are understood, nu-
clear RNA export is highly selective and is mainly mediated by a protein family
termed exportins (karyopherins). These exportins depend on the activity of a
small co-factor, the GTPase Ran [Allen et al., 2000]. In case of Drosha-processed
pre-miRNAs Exportin5 (Exp5) forms a heterotrimer with Ran and pre-miRNA,
whereas the binding of Exp5 depends on the RNA structure but not on the se-
quence. After passing the NPC Ran-GTP is hydrolyzed to Ran-GDP and the
pre-miRNA is released [Cullen, 2004].
In the cytoplasm pre-miRNAs undergo a final processing step: Dicer, a RNase
III enzyme, binds the double stranded pre-miRNA and cuts both strands of the
stem loop, generating a ∼22 nucleotide miRNA duplex. One strand is incorpo-
rated into RISC, whereas the other miRNA∗ strand is typically degraded [Bushati
and Cohen, 2007].
In contrast mRNA export does not depend on Ran and karyopherins but de-
pends on various other RNA binding proteins. Furthermore, the NPC recognizes
and transports only completely processed mRNAs. Presumably, the recognition
depends on cap-binding, poly-A-tail and further binding of appropriate proteins.
Key proteins mediating the export of mRNA are Tap and a small co-factor
termed Nxt (p15) that form a heterodimer. However, by recruitment of further
proteins like UAP56 and RNA-dependent ATPases the ribonucleoprotein com-
plexes (RNP complexes) is recognized by NPC and the intron free mRNA is
exported to the cytoplasm [Iglesias and Stutz, 2008].
An exported mRNA binds to ribosomes, which translate it into a polypeptide.
Some mRNAs are directed to specific intracellular locations. The direction is
controlled by specific sequences mainly within 3’ UTR, but also in the 5’ UTR,
recognized by RNA binding proteins (RNPs). These transport RNPs engage with
cytoskeletal motors for directed transport. During transport several mechanisms,
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presumably including small non-codingRNAs and further RNA binding proteins
inhibit the translation of transported mRNA [Besse and Ephrussi, 2008]. Be-
yond this spatial component, a temporal regulatory impact of these mechanisms
controlling gene expression is assumed.
1.1.3.2 mRNA degradation or turnover
The protein production is further regulated by the mRNA lifespan. In general
mRNA molecules are unstable and consistently degraded. Different eukaryotic
mRNAs have different half-lives, ranging from several minutes to more than 10
hours (β-globulin mRNA) [Alberts et al., 2002]. Several independent mechanisms
control mRNA turnover. Besides the common pathway, that is deadenylation
followed by exosome complex mediated degradation, there is also cleavage by
sequence-specific endonucleases or cleavage in response to the binding of comple-
mentary small interfering RNA (siRNAs) or miRNAs [Parker and Song, 2004].
Nearly all ∼200 bp long poly-A-tails of eukaryotic mRNAs are continuously
shortened by a variety of deadenylases in a 3’ to 5’ direction. Once the tail reaches
a critical length, the 5’ cap is removed and the mRNA is rapidly degraded.
Decapping allows for additional digestion in 5’ → 3’ direction by exonucleases.
Furthermore, after deadenylation the exosome, a huge protein complex containing
multiple exoribonucleases [Newbury, 2006], degrades mRNA from the 3’ end. This
protein complex is also involved in nonsense-mediated decay [Lejeune et al., 2003;
Lehner and Sanderson, 2004], a mechanism detecting nonsense mutations and
prevents the production of truncated or erroneous proteins by RNA degradation.
The rate of poly-A tail shortening varies from mRNA to mRNA and depends
on several RNA-binding molecules which can decrease or increase the rate of
deadenylation.
The cleavage of mRNA is mainly controlled by siRNA. Short double-stranded
RNA molecules processed by Dicer and integrated into RISC, bind to comple-
mentary mRNA sequences and induce enzymatic cleavage [Moazed, 2009]. This
process is strongly related to miRNA mediated translational control and will be
discussed in detail in the next chapter.
Many untranslated mRNAs assemble in related mRNPs that accumulate in
specific loci termed P bodies [Parker and Sheth, 2007]. P bodies interact with the
decay machinery and associated mRNAs can either be degraded after decapping,
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remain in the P body state or reentry translation. Although many questions
concerning the function of P bodies are unclear, their role in modulation of gene
expression is indisputable.
1.1.3.3 MicroRNAs
Shortly after their discovery in the 1990s, the interest in miRNAs extremely
increased due to the discovery of their impact on protein coding gene expression.
After a miRNA is embedded into RISC, it binds to specific sequences mainly in
the 3’ UTRs of mRNAs and inhibits translation or causes degradation initiated
by cleavage of the poly-A-tail [Grosshans and Filipowicz, 2008].
Recognition of target sites depends on extensive complementary pairing but
does not require a complete match over the full miRNA length. Most miRNA
binding sites identified so far include a complete 7-8mer pairing in the ‘seed’
region of the miRNA. This region is defined as the nucleotides 2-7 from the 5’ end
of the miRNA [Bartel, 2009]. Beside these canonical seed-matched sites several
6mer pairing sites and even seed mismatch sites are verified to be functional
[Brennecke et al., 2005]. However, sites with insufficient 5’ pairing seem to require
strong 3’ pairing, indicating that besides pairing the free energy also affects the
stability of the miRNA:mRNA duplex [Doench and Sharp, 2004].
MicroRNAs loaded into RISC modulate gene expression mainly by downreg-
ulation of the rate of translation. This can be achieved by two different mecha-
nisms: mRNA cleavage and translational inhibition. Cleavage of mRNA depends
on sufficient complementarity of the miRNA and is identical to the siRNA path-
way. In animals where miRNAs target mRNAs mainly by an imperfect match
the latter mechanism, which leads to translational repression, outbalances. Two
different modes of repression are currently discussed. Repression of initiation
of translation and repression of elongation of the polyaminoacid chain [Cannell
et al., 2008]. However, recently it has been shown that miRNAs can also activate
translation of target mRNA [Vasudevan et al., 2007].
Furthermore, repression of target activity can be classified into three main
categories: ‘Switch’, ‘fine tuning’ and ‘neutral’ [Flynt and Lai, 2008]. Whereas
switch refers to a inhibition of protein synthesis towards a target inactivity,
tuned targets still produce functional proteins but in a lower amount. Functional
miRNA:mRNA interactions without advantageous nor adverse consequences are
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denoted as neutral, since their effect on the phenotype is negligible. Differentia-
tion between tuning and switch depends on the impact of translational repression.
Properties modulating the impact are characteristics of the seed, GC-content
(guanine-cytosine content) and the number of functional binding sites within the
3’ UTR [Baek et al., 2008].
Like TFs miRNAs are affecting their target genes in different miRNA com-
binations and a single miRNA can target up to hundreds of different mRNAs
[Betel et al., 2008]. As a consequence, the combinatorial scope allows for complex
regulatory networks controlling the expression of thousands of protein coding-
genes. Considering that also TFs are targets of miRNAs and in turn control their
transcription, too, extensive linkage between both regulatory networks holds for
multiple sources of information to control expression of individual transcripts. So
far, little is known about global and local structures of these networks but recent
studies provide more and more insight into the architecture and components or
motifs it is composed of [Shalgi et al., 2007; Tsang et al., 2007; Yu et al., 2008].
1.2 Measuring gene expression
In the last chapter the mammalian transcriptome was briefly introduced and the
most prominent RNA types were discussed. Furthermore, we discussed the main
regulatory mechanisms controlling the expression of genes. In this chapter we will
shortly discuss several methods that are used to measure gene expression based
on RNA levels. In principle one can differentiate between methods measuring
the expression of single RNA molecules or large scale methods, which are able to
measure the expression of thousands of genes at once. In this work we exclusively
focus on the analysis of high throughput expression data. The most commonly
used method to measure large scale gene expression is the microarray technology
[Kawasaki, 2006]. Further methods are serial analysis of gene expression (SAGE)
[Anisimov, 2008] and Deep sequencing [Wang et al., 2009].
In the following sections the principles of microarray technology will be intro-
duced and the applicability as well as the main issues and restrictions will be
discussed.
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1.2.1 Microarray technology
A microarray or genechip is a tool which allows to measure the expression of
thousands of genes simultaneously. Although different techniques exist the tech-
nical principle is mainly identical. On a small support, consisting of a membrane
or glass slide, probes are immobilized by covalent bonds to a chemical matrix.
These probes can be short DNA fragments, cDNA or oligonucleotide sequences
organized in so-called spots, complementary to nucleotide sequences of known
transcripts. In spotted arrays probes are synthesized prior to deposition on the
array surface and are then ‘spotted’ onto glass. In oligonucleotide microarrays,
the probes are mostly synthesized directly onto the support.
Fluorescent-labeled cDNA molecules derived from isolated mRNA from each
cell type studied are then hybridized to the genechip. Within spotted arrays one
often hybridizes control and sample cDNA or cRNA labelled with two different
fluorescent dyes onto one chip, whereas in oligonucleotide arrays only one color
channel is used. Control and sample RNA are therefore hybridized to different
chips. The measured fluorescence intensities for each spot mirrors the relative
expression of the corresponding transcripts. Changes in gene expression can be
estimated by computational comparison of the measured expression levels.
In this work only one channel oligonucleotide microarrays as manufactured by
Affymetrix were used. Further reading about technical background, probe level
data and probe annotation can be found in [Affymetrix, 2001; Irizarry et al., 2003;
Liu et al., 2003]. After several normalization and preprocessing steps huge data
sets of gene expression are obtained [Sarkar et al., 2009]. Typically one denotes
the columns as the samples or gene expression profiles (GEPs) and the rows,
representing the expression level of each gene across all experimental conditions.
The proper analysis of such data is an elaborate task and will be extensively
discussed in the next sections.
1.2.2 Limitations
Microarray technology benefits from its high throughput characteristics, but un-
like methods like SAGE and Deep sequencing, it is a closed method that is
limited to the genes that are represented on the chip. However, not all genes or
transcripts are known yet or sequences are wrongly identified during genome an-
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notation. A further disadvantage, compared to gene expression profiling methods
like QPCR (quantitative PCR), is that it lacks accuracy. The main reason for
impreciseness in measuring the expression of a particular transcript is caused by
cross-hybridization, annealing of only partially complementary sequences. Fur-
thermore, probes designed from genomic EST information may be incorrectly
associated with a transcript of a specific gene.
Since a particular probe is mainly designed to match parts of the sequence
of known or predicted open reading frames, different splice forms of a single
genes can not be determined. Moreover, genechips only detect mRNA levels.
As described above, these are subjects to comprehensive post-transcriptional
regulatory mechanisms and though not obligatory translated into protein. These
restrictions to gene expression stay obscure within a microarray experiment.
1.3 Statistical methods and analysis models
The first sections in this chapter contained a brief summary of the regulation and
composition of the mammalian transcriptome. Several regulatory mechanisms
and their interactions were described, to show the complexity of gene expres-
sion regulation. In the last section microarray technology, a widely used method
that allows for the simultaneous measurement of the activity of thousands of dif-
ferent genes, was introduced. Microarray experiments produce high-dimensional
data with little replication, thereby causing several problems of statistical anal-
ysis. The complexity and huge amounts of data pose for several bioinformatic
challenges, ranging from pre-processing steps like background correction, data
normalization and filtering over to gene annotation and data warehousing [Autio
et al., 2009; Hackstadt and Hess, 2009; Stekel, 2003].
In this work we mainly focus on the statistical analysis of pre-processed gene
expression data. The goal is to extract meaningful biological information. Typical
biological goals addressed by microarray experiments include the identification
of co-expressed genes, identification of genes or groups of genes with expression
patterns related to experimental conditions (chemical treatment) or different cell
types (tumor vs wild type), or the identification of regulatory relationships (TF
- target gene).
In the field of microarray data analysis a lot of different statistical tools and
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methods have been developed to achieve the above mentioned goals of the biolog-
ical tasks. A common classification of these methods is the distinction between
supervised and unsupervised methods. Supervised methods use prior knowledge
about samples or genes to extract patterns or features specific to a given class
or to classify samples or genes [Lutter et al., 2006]. In contrast, unsupervised
methods screen the data for interesting novel biological regularities or relation-
ships. Additionally, one can also classify analysis methods as clustering methods,
projection methods or graphical model based approaches. However, all these
methods are widely discussed and precisely explained in a number of articles,
reviews and books [Quackenbush, 2006; Dougherty et al., 2005; Allison et al.,
2006; Berrar et al., 2003].
In the following, we will discuss several analysis methods based on the un-
derlying biological model conceptions. Concerning the biological background one
can distinguish between two main models: mapping models and mixture models.
Mapping models are based on the assumption that each measured gene expression
profile corresponds to a specific cellular state, chemical treatment or experimen-
tal condition, whereas mixture models are based on the assumption that a gene
expression profile is composed of several biological processes running in parallel.
Each process is responsible for a particular expression profile. In the following,
these model conceptions and the corresponding statistical tools used in this work
will be discussed. The applicability of these tools on microarray data and the bi-
ological questions that give rise to the use of a particular analysis method will
be discussed below.
As mentioned above, only Affymetrix oligonucleotide gene chips were used in
this work. Therefore, the following methods mainly refer to one channel gene
expression profile data. However, most of these methods can be applied in a
slightly modified way to two channel data as well.
1.3.1 Mapping models
Typically a microarray measurement is considered as a map of the cellular gene
expression, based on mRNA levels, at a distinct time point and under certain
— inner and outer — conditions. Inner conditions may refer to a developmental
stage or alteration in the genotype, whereas outer conditions may be chemical
treatments, starvation or physical stress. Different conditions cause the cell to re-
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act with a modification in gene expression. Changes in expression patterns can be
interpreted as the phenotypic expression of regulatory mechanisms. For instance,
comparing expression profiles of a TF knock-out experiment to wild type profiles
will produce a list of up and downregulated genes, which can be interpreted as
negatively or positively regulated TF target genes. Moreover, the differences in
the temporal expression profiles of differentiating cells provide information about
the activated or inactivated pathways.
Based on these model assumptions several statistical methods have been estab-
lished that generate interpretable biological results. The most commonly used of
these methods will be discussed in this work with regard to the above mentioned
underlying biological mechanisms. In the following the expression value of a gene
k in the nth of N experiments is written as xkn. Two different experimental con-
ditions can be denoted as “+” and “−”, which reads then as xk(+) and xk(−)
the expression of a gene k under two conditions for instance as treatment and
control.
1.3.1.1 Pairwise comparison
The most canonical approach in the analysis of different gene expression patterns
is to look for differentially expressed genes. The goal is to identify genes changing
their expression significantly from one state to another. Dependent on the size of
the dataset several methods are commonly used to identify these genes [Cui and
Churchill, 2003]. Three of these will be exemplary listed and shortly specified.
 A fold change denotes the relative change in gene expression between two
distinct experimental conditions ±. For a gene k it depends on the log-ratio
SignalLogRatiok = log2
xk(+)
xk(−) (1.1)
If replicates for the conditions are available one typically uses the estimated
means xi = xi(±). The fold change for gene k can then be defined as
FoldChangek =
(
2SignalLogRatiok , SignalLogRatiok ≥ 0
−2−SignalLogRatiok , SignalLogRatiok < 0
. (1.2)
The fold change is not a statistical test, and does not provide any associated
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value that can indicate the level of confidence. Furthermore it is subject to
bias caused by improperly normalized data or outliers.
 The t-test is a simple statistical test to detect differentially expressed
genes. It compares two distributions, assumed to be Gaussian, to test
whether the means are different. Applied to a two class microarray ex-
periment it can be used to determine significantly differentially expressed
genes. The power of the test depends on the number of samples, and there-
fore, is low for microarray experiments where the sample size is typically
small. Furthermore, it may suffer from the same bias as the fold change if
the error variance is not truly constant for all genes.
 Significance analysis of microarrays (SAM) is a further, widely used method
to determine differentially expressed genes [Tusher et al., 2001]. It assigns
a score to each gene, relative to the standard deviation of repeated
measurements, based on changes in expression between two conditions. The
algorithm estimates a false discovery rate (FDR) using permutations of the
replicates that can be used to adjust a threshold to identify significantly
regulated genes. The test is more robust for small sample sizes then the
t-test, and does not assume normal distributions.
However, all of these methods only allow for a pairwise comparison of two differ-
ent conditions. They rank genes accordingly to their change in expression and —
if applicable — provide a significance measure. The biological meaning of these
lists has to be interpreted carefully. Depending on the quality of the data or
normalization errors false positives may occur. Furthermore, one can not distin-
guish between direct or indirect regulatory effects and, since cells react in many
different ways on different treatments, genes showing high differential expression
do not necessarily share a common function. Finally, these methods imply a rela-
tionship between differentially expressed genes and the experimental treatment.
But the strength in alteration of expression does not depend on the regulatory
impact a particular gene has. Hence, several potentially interesting genes may
not be detected within a pairwise comparison analysis.
35
Figure 1.3: Hierarchical clustering of toy gene expression data. Relative expression
levels are color coded; red indicates positive and green negative values. Distances were
measured using four different similarity criterions: single-, complete-, average linkage
and Ward’s criterion. Depending on the criterion, the four resulting trees show different
topologies.
1.3.1.2 Hierarchical clustering
A somewhat related approach to the detection of differentially expressed genes
is the identification of similarities in gene expression patterns. However, unlike
comparing the expression of a single gene in different conditions, one here com-
pares the expression patterns of multiple genes with each other. One major goal
of this analysis is to identify genes with positively or negatively correlated ex-
pression patterns. Genes with a positive correlation in depending on different
conditions therefore may also share a common biological function or even are
commonly regulated. In contrast, negative correlation of two or more expressed
genes may indicate for more or less antagonistic functions.
A common approach to identify correlated genes is clustering. As clustering
one denotes the assignment of objects into groups (called clusters) depending
on a similarity measure. The objects assigned to the resulting clusters are more
similar to each other than objects from different clusters. Similarity is often
assessed according to several distance measures, such as euclidean distance or
Pearson correlation [Sturn et al., 2002].
Although a bunch of different clustering algorithms exist, in the field of mi-
croarray data analysis the most commonly used method is hierarchical clustering
[Quackenbush, 2001]. The algorithm iteratively connects genes accordingly to
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their similarity, beginning with the most similar ones. The result is a tree or
dendrogram where the branches connect the grouped genes. Cutting the tree at
a predefined threshold will give a clustering at the selected precision. Beyond the
choice of an appropriate distance measure between distinct genes, the similar-
ity between groups has to be defined, also. Usually the similarity between two
clusters can be determined as:
 Single linkage or nearest neighbour method. The distance between two
clusters i and j is defined as the minimum distance between the elements
of each cluster.
 Complete linkage or maximum neighbour method. The distance between
two clusters i and j is calculated as the maximum distance between an
element of cluster i and an element of cluster j.
 Average linkage unweighted pair group method (UPGMA). The distance
between two clusters is calculated based on the average values using all
elements of each cluster.
 Ward’s criterion. At each step in the analysis, the union of every possible
cluster i and j is considered and the two clusters whose fusion results in
minimum increase in ’information loss’ are combined. Information loss is
defined by Ward in terms of an error sum-of-squares criterion, ESS.
Although the algorithm is easy to understand and the results are intuitively in-
terpretable, it also lacks several issues. Depending on the height of the cut of
the tree, the size and number of distinct clusters varies. Defining the height that
results in the most relevant clusters can not be easily determined. Furthermore,
depending on the used distance metric or linkage method, the resulting den-
drograms vary (see figure 1.3). Hence, the interpretation of the different results
may be misleading or even false. The strength of his method is the unsupervised
identification of interesting gene expression patterns. A huge gene cluster show-
ing a distinct pattern can provide novel biological information about regulatory
mechanisms. By contrast, a single gene of potential interest may not be identified
since it is not assigned to a conspicuous cluster (see chapter 4).
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Figure 1.4: SVM classifier. (A) Binary classification. The data is linerly separable by
infinite hyperplanes, e.g. h1 . . .h3. (B) A SVM finds the optimal hyperplane hopt with
its normal vector wopt and the maximum distance to the support vectors (circles). (C)
The SVM is trained using a training data set. (D) A new object can the be classified.
1.3.1.3 Support vector machines
Beyond the identification of strongly differentially expressed genes or genes with
common regulatory patterns, one can also try to identify genes, that allow for
classification of the dataset. An appropriate and widely used method for this gene
selection task is the application of a support vector machine (SVM) [Schachtner
et al., 2007a; Herold et al., 2008]. This supervised learning approach estimates
an optimal hyperplane h which can be characterized by its normal vector w and
a constant b. After training using a finite set of training data, the hyperplane
separates the input data into two classes.
The SVM mechanism can be easily illustrated using geometric considerations
in a vector space. The training dataset consists of K gene expression profiles.
Each gene expression profile is represented by a vector formed by N gene expres-
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sion values, labeled by two classes. Based on the data, an optimal hyperplane
is estimated, that has the maximum possible distance to the training vectors
(support vectors) closest to it (see figure 1.4B), and is then characterized by its
normal vector wopt. After estimating the optimal hyperplane a new vector x can
be classified according to the decision function (see figures 1.4C,D)
f(x) = sgn(〈x,w〉+ b), (1.3)
where
w =
X
m∈SV
ymαmx
SV
k (1.4)
and ym represents the class label, αm represents a hyperparameter and x
SV
k indi-
cates the support vectors closest to the separating hyperplane. The components
of wopt indicate the importance of a gene for the classification task. Genes with
small components in wopt can be removed as their associated unit vector lies
almost parallel to the hyperplane and therefore orthogonal to the optimal class
discrimination. Hence, in reverse one can now identify a minimum number of
genes, that allow for correct classification. These selected genes may then be
used as so-called marker genes, for instance in clinical approaches like cancer
classification.
In some cases it might be the case that the data is not linearly separable. In
these cases, one can either use soft margin hyperplanes, which allow for some few
points to be wrongly classified, or non-linear SVM, where the data is projected
into a higher dimensional space using a ‘kernel’ before classification [Scholkopf
and Smola, 2002].
Similar to the pairwise comparison methods, SVMs are based on the power
of single gene statistics. Thus, the quality of the trained classifier depends on
proper gene expression value normalization. Another problem that may occur is
overfitting, especially when the number of features (genes in this case) is large
compared to the number of training samples. Unfortunately this is mostly the
case in microarray data analysis. To avoid overfitting a preselection of genes,
based on gene ranking using pairwise comparison methods, can be applied. Fur-
thermore, in principle SVM are only able to be trained on two different classes.
However, apart from these more technical issues, one emerging problem of
SVMs is the potentially misleading interpretation of the selected genes. Genes,
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that are used to correctly classify the data, are not necessarily genes, strongly
related to the conditions under study and, by contrast, genes with a major bio-
logical role may not be applicable for classification.
1.3.2 Mixture models
The basic assumption in the previously discussed mapping models is that the
change in gene expression – more or less – directly corresponds to the different
conditions. However, according to our knowledge, one gene can be associated
with several functions. Thus, a single gene can produce different splice forms
with corresponding proteins related to specific tissues or functions [Holmberg
et al., 2000; Ryan et al., 2005] and further on, a distinct protein can be part
of several pathways or biological processes at once [Alberts et al., 2002]. The
composition of the transcriptome within a living cell is controlled by a couple
of biological processes, each of which causing its own specific gene expression
pattern, the so called gene expression mode (GEM). Hence, the expression of
a single gene may then be a result of more then one regulatory mechanism.
Therefore, we consider a GEP xn = (xn1, . . . , xnK), n = 1 . . . N, as the expression
level of K genes measured under N conditions resulting in a expression matrix
X = (x1, . . . ,xN), where the columns are formed by the GEPs and the rows
correspond to the expression patterns of the distinct genes.
According to this conception, a specific gene expression profile, measured at a
distinct condition is then the superposition of simultaneously running processes,
each represented by its own GEM. The goal of the following methods is the re-
construction of these GEMs. Unfortunately, the number and properties of the
underlying processes are unknown and therefore, the number of possible solu-
tions is infinite. Hence, one has to impose additional restrictions to the model.
In general this problem can be specified as a blind source separation (BSS) prob-
lem, where one tries to recover signals from several observed linear mixtures. In
our case mixtures refer to microarray measurements. The following methods are
based on decorrelation, independence or non-negativity of the unknown source
GEMs. All these methods were developed in the field of linear algebra and are
also successfully applied to other BSS problems like removing water artefact’s
from NMR spectra or functional RMI data analysis [Stadlthanner et al., 2003b;
Theis et al., 2005; Bo¨hm et al., 2006].
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Figure 1.5: Illustration of the mixing model. K genes differentially contribute to three
independent GEMs. Dependent on three different conditions the GEMs are more or less
active and superimpose to the three measured GEPs.
1.3.2.1 Principal component analysis
One possible approach is to assume that the underlying GEMs forming a GEP
are decorrelated. Correlation is a basic statistical measure indicating the strength
and direction of a linear relationship between two random variables. Principle
component analysis (PCA) is a widely used method that allows for the decom-
position of several possibly correlated signals into an equal or smaller number of
uncorrelated variables. Mathematically speaking, a PCA is a linear transforma-
tion that projects multivariate data into a new orthogonal feature space where
the first principal component (PC) refers to the direction with the greatest vari-
ance and lies on the first new coordinate [Hyva¨rinen et al., 2001].
Given our data matrix X where the columns represent the GEPs measured in
a microarray experiment and the rows are formed by the single gene expression
patterns. PCA now finds an orthogonal transformation U such that
YT = XTU = VΣ. (1.5)
The columns of the matrix Y are the principal components, and the columns
of U form the set of orthonormal basis vectors of the PCs. The matrix Σ is a
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diagonal matrix containing the singular values of X.
As PCA extracts and sorts the PCs according to their variance in decreasing
order, a common application is dimensionality reduction. Given the noise present
in real data, one can concentrate on the first l components assuming they contain
almost all relevant information. In practice a reasonable determination of l is
problematic since the amount of noise is generally unknown and the number of
components required for a sufficient biological interpretation is hard to define.
However, the application of PCA as a preprocessing step for clustering, com-
pared to clustering of the original data does not necessarily improve cluster qual-
ity [Yeung and Ruzzo, 2001]. Since, in this work PCA is only applied as a neces-
sary preprocessing step for independent component analysis (see next section),
we here will refrain from a more detailed discussion of PCA.
1.3.2.2 Independent component analysis
The power of PCA is restricted to second order statistics. Independent compo-
nent analysis (ICA) uses the much richer requirement of statistical independence
to decompose a given set of measurements into independent source signals so-
called independent components (ICs) [Theis, 2002]. To solve this problem, several
ICA algorithms have been developed. In this work the two well-established algo-
rithms, JADE [Cardoso et al., 1993; Cardoso and Souloumiac, 1996] and FastICA
[Hyva¨rinen, 1999], implemented in MATLAB® [Mathworks, 2008] were used.
Applied to the analysis of large scale gene expression data, several model as-
sumptions have to be made [Lutter et al., 2008, 2009]. Briefly summarized, gene
expression of K genes in a living cell is controlled by M independent biological
processes running in parallel. Each process m ∈ {1, . . . ,M} forms a distinct GEM
represented by a row vector of K gene expression levels sm = (sm1, . . . , smK).
Note that one gene can be part of more than one process/GEM. The respective
GEMs superimpose to a measureable GEP (columns of our data matrix X). Al-
though, from our comprehension of the biology of a living cell, no single process
is completely isolated, and therefore all processes somehow interact between each
other. However, due to a certain autonomy of these processes one can assume
that the corresponding GEMs appear to be independent, to a first approximation.
ICA decomposes our data X into a matrix of M independent expression modes
S = (s1, . . . , sM) and the corresponding N ×M mixing matrix A including the
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basis vectors of our new feature space, which then reads as
XT = AS. (1.6)
Each microarray expression measurement xn (columns of X) results from a
weighted superposition of independent biological processes. The mixing matrix
A defines the weights with which the corresponding GEM contributes to the
measurements or GEPs.
In practice, statistical independence can not directly be determined and there-
fore, has to be approximated. A common approach to solve this is to approximate
independence by non-gaussianity. Non-gaussianity again can be measured by the
fourth-order cumulant, the kurtosis. A second measure of non-gaussianity is given
by negentropy, which is based on the information-theoretic quantity of entropy
[Hyva¨rinen et al., 2001]. Although further approximations exist, the algorithms
used in this work are either based on the kurtosis (JADE) or approximate non-
gaussianity using negentopy (FastICA). Furthermore, the reconstruction of inde-
pendent source signals due to a linear mixture model is limited to two ambiguities
[Hyva¨rinen et al., 2001]:
1. The energy of the variances of the independent signals can not be deter-
mined.
2. The order of the reconstructed independent components can not be deter-
mined.
Since microarray technology is only capable to measure relative gene expressions
(see section 1.2), the first ambiguity is primarily extraneous here. Note that this
still leaves the indeterminacy of the sign of the components. Typically, as a result
from an ICA one obtains ICs with positive and negative entries, but negative
gene expression does not exist. The negative expressions may be considered as
related to strongly repressed processes. But, since the sign is unknown, from our
gene expression mixture model, it is — without using additional knowledge —
impossible to determine whether a strong reconstructed signal corresponds to an
activated or repressed biological process.
The second ambiguity is almost equally negligible since we cannot assume
that there is any order of the biological processes. However, more relevant for a
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meaningful interpretation of the results is the relation of a GEM to a specific ex-
perimental condition. In case of a time course experiment, the temporal activity
of a particular process gives insight into the inner organization of a cell. For in-
stance, in [Lutter et al., 2009] it is shown how a time dependent cellular response
to bacterial infection could be reconstructed from determining the contributions
of the GEM to the GEP from the mixing matrix A.
A further limitation to ICA is the indeterminacy in the overcomplete case.
This means, that a unique reconstruction of independent components can only
be assured if the number of reconstructed signals is less or equal to the number
of used mixtures [Theis and Lang, 2002; Theis et al., 2004a]. Unfortunately,
the number of cellular processes is generally unknown. One reconstructed GEM
may therefore still represent a superposition of underlying processes. Using a
bootstrapping approach, it could be shown that sampled reconstruction is more
robust compared to a random model [Lutter et al., 2009] and the results may
therefore be interpreted as GEMs referring to single or superpositions of strongly
related processes.
1.3.2.3 Non-negative matrix factorization
As a result of an ICA analysis one obtains independent source signals with posi-
tive and negative entries. As mentioned the sign of these signals is undetermined,
provoking the discussed issue. The Non-negative Matrix Factorization (NMF)
techniques replace the assumption of statistical independence by a positivity
constraint concerning the entries of the matrices into which the measured GEPs
are decomposed [Schachtner et al., 2008]. This constraint of non-negativity seems
to be more adequate to microarray data, since gene expressions are measured by
strictly positive fluorescence intensities. Applied to our data matrix X, where
each column represents a GEP and each row a gene expression pattern, NMF
approximately factorizes a matrix X into a product of two non-negative matrices
W(K × L) and H(L×N) such that
X ≈WH (1.7)
where the common approach is to minimize ||X−WH||. The columns of W are
called metagenes, while rows of H constitute meta experiments [Brunet et al.,
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2004], where L is an integer parameter to be set. In analogy to the ICA mixing
model, the metagenes can be interpreted as a particular gene expression mode
that is characteristic for a specific biological process. The meta experiments con-
tain the mixing coefficients defining the contributions of each metagene to the
experiments. The results can be used to search for potentially interesting source
signals, which help to identify putative marker genes [Schachtner et al., 2007b].
For instance one can search for a specific pattern within the meta experiments
to focus only on the genes contained in the corresponding metagene.
However, it has been shown that non-negativity being the only constraint does
not lead to unique results [Lee and Seung, 1999, 2001]. As mentioned above,
since the number of underlying processes is not known, some more flexibility
concerning the number of estimateable sources would be of advantage. By varying
the number of estimated sources combined with extensive sampling reproduceable
results can be achieved. But in comparison to other well-founded methods, this
method still holds the drawback of manual thresholding [Schachtner et al., 2008].
However, in analogy with the ICA model, the number of biological processes to be
identified is unclear and, thus one may obtain either superpositions or partially
fragmented reconstructed GEMs.
One further solution to increase robustness, is to extend NMF algorithms by
additional constraints. In case of reconstruction of GEMs due to biological pro-
cesses, it is assumed that these processes only correspond to the expression of a
few genes, compared to a complete GEP measured with microarrays. Hence, a
sparseness measure can be proposed as most appropriate to suitably transform
gene expression profiles into interpretable underlying biological signals. Several
algorithms applying additional sparseness constraints have been proposed, but
either still do not deliver unique results or are extremely computationally exten-
sive [Li et al., 2001; Stadlthanner et al., 2007].
1.4 Conclusions
In this last chapter the basic principles of gene expressionwere outlined and the
widely used method of microarray technology was introduced. We then discussed
various analysis methods based on two different underlying models towards their
biological relevance. In most cases the outcome of these methods is a list of
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genes of interest. To further interpret these gene lists, a common approach is
to create graphs where the nodes represent genes and the edges between the
nodes represent distinct relationships between two genes. These relationships
can be defined in various ways. For instance one can use gene annotation as
provided by the Gene Ontology [Ashburner et al., 2000] or the MeSH database
[Nelson et al., 2004]. Another reasonable approach is to use text mining tools
as provided by Genomatix® [Genomatix, 2009] or protein-protein interaction
networks. The advantages of the representation of genes in a network a diverse.
On the one hand a network presentation allows for a more intuitive interpretation
of results, where genes related to a specific pathway or involved in a common
biological process become easily visible. On the other hand graphs allow for
additional analysis methods based on graph theory. These methods can be used to
identify interesting network structures or over-represented motifs. In the following
network representation will be repeatedly used to illustrate and to interpret the
results.
46
2 Analyzing M-CSF dependent
monocyte/macrophage differentiation:
expression modes and meta-modes derived
from an independent component analysis
2.1 Background
Since microarray technology has become one of the most popular approaches
in the field of gene expression analysis, numerous statistical methods have been
used to provide insights into the biological mechanisms of gene expression regu-
lation. The high dimension of expression data and the complexity of the regula-
tory mechanisms leading to transcriptional networks still forces statisticians and
bioinformaticians to examine available methods and to develop new sophisticated
approaches. However, there are already appropriate methods using different ap-
proaches to examine the underlying biological mechanisms determining the gene
expression signatures and profiles measured by microarray experiments. Super-
vised methods using prior knowledge like Gene Set Enrichment Analysis (GSEA)
deliver useful results under certain conditions. But there is still a lack of reliable
data needed for non-classical analysis. Widely used unsupervised approaches, like
hierarchical clustering and k-means clustering, use correlations or other distance
or similarity measures to identify genes with similar behavior under similar con-
ditions. But these methods are not able to represent more complex structures
and interdependencies in the regulatory machinery.
In contrast to the algorithms mentioned above, independent component analy-
sis (ICA) explores higher-order statistics to decompose observed gene expression
signatures (GES), which form the rows of the input data matrix, into statisti-
cally independent gene expression modes (GEM), which form the rows of matrix
S according to the data model XT = AS. ICA solves blind source separation
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(BSS) problems, where it is known that the observed data set represents a linear
superposition of underlying independent source signals. But it can more generally
be considered a matrix decomposition technique which extracts informative fea-
tures from multivariate data sets like, for example, biomedical signals like EEG
(Electroencephalography) [Habl et al., 2000], MEG (Magnetoencephalography)
[Vigario et al., 1997] and fMRI (functional magnetic resonance imaging) [Yang
and Rajapakse, 2004; Keck et al., 2004; Theis et al., 2004b] recordings. ICA can
also be considered a projective subspace technique appropriate for noise reduc-
tion [Tome´ et al., 2004; Gruber et al., 2006], or artifact removal [Stadlthanner
et al., 2003a, 2005] if generated from independent sources.
In this work we will concentrate on the linear case, in which each single mi-
croarray GES is considered a linear superposition of unknown statistically in-
dependent GEM. To decompose these mixtures into statistically independent
components, ICA algorithms like FastICA or JADE have been used. Typically,
these GEMs can be interpreted as being characteristic of ongoing, largely inde-
pendent biological regulatory processes. The philosophy behind can be expressed
as: co-expression means co-regulation. But the complexity of gene regulation and
the various interactions of cellular processes demands a new interpretation of our
ICA-derived components. In the following we use these extracted GEMs to gen-
erate sub-modes, which may provide biological pathway information. The genes
contained in these pathway-associated sub-modes can be regarded as more or less
self-contained parts of larger regulatory networks, which can be represented by
combining these sub-modes into meta-modes according to the functional role of
the associated genes.
Here we used M-CSF dependent in vitro differentiation of human monocytes to
macrophages as a model process to demonstrate that ICA is a useful tool to sup-
port and extend knowledge-based strategies and to identify complex regulatory
networks or novel regulatory candidate genes.
The major known pathways associated to M-CSF receptor dependent sig-
naling [Shi and Simon, 2006; Pixley and Stanley, 2004; Ross and Teitelbaum,
2005] include expansion of the role of the MAP-kinase pathway [Wada and Pen-
ninger, 2004; Bogoyevitch et al., 2004] and Jun/Fos, Jak/Stat and PI-3 kinase
[BehreDagger et al., 1999; Fox et al., 2003; Stephens et al., 2002] dependent signal
transduction. Up-regulation of immune-regulatory components involved in innate
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immunity response (e.g. MHC), specific (e.g. Fcγ) [Houde et al., 2003; Vieira
et al., 2002; Booth et al., 2001] and nonspecific (CRP, complement, galectins)
[Sobota et al., 2005; Swanson and Hoppe, 2004; Mina-Osorio and Ortega, 2004;
Lau et al., 2005; Dumic et al., 2006] opsonin receptors as well as charge and
motif pattern recognition receptors (e.g. SR-family, LRP, Siglecs etc.)[Fabriek
et al., 2005; Minami et al., 2001; Beutler, 2004; Lock et al., 2004], is characteris-
tic for monocyte/macrophage differentiation. Beyond this, an increase of mem-
brane biogenesis, vesicular trafficking and metabolic pathways including amino
acids, glucose, fatty acids and sterols, as well as increased activity of lysosomal
hydrolases that enhance phagocytotic function [Desjardins, 2003; Martin and
Parton, 2006], autophagy [Schmitz and Buechler, 2002] and recycling is trig-
gered through M-CSF signaling as a hallmark of innate immunity [Peiser et al.,
2002]. These mechanisms are tightly coupled to changes in cytokine/chemokine
response [Branton and Kopp, 1999] and red/ox signaling (NOS e.g. NADPH-
Oxidase, Glutathione, Thioredoxin, Selenoproteins) that drive chemotaxis migra-
tion, inflammation (e.g.NfκB), apoptosis (eg. Caspases, TP53, NfκB, ceramide)
and survival [Forman and Torres, 2002; Nordberg and Arner, 2001; Wang et al.,
2006a,b; Cathcart, 2004; Kustermans et al., 2005; Østerud and Bjørklid., 2003].
2.2 Results and Discussion
M-CSF dependent monocyte to macrophage differentiation involves the activa-
tion and regulation of many different cellular pathways. In this study we used
several microarray experiments and combined them to a data set, which we ana-
lyzed using the JADE algorithm. The extracted GEMs were labeled from 1 to 14,
according to decreasing energy. Note that the extracted GEMs show positive as
well as negative components. They are partitioned into a sub-mode containing the
negative signals only, denoted by i.1, and a corresponding sub-mode of the pos-
itive signals, denoted by i.2, respectively. These sub-modes were then combined
into so-called meta-modes according to the following super categories deduced
from the MeSH-filter used: Apoptosis, signal transduction, cell cycle and regula-
tory sequences, see table 2.1. Sub-classification and mapping to distinct pathways
was then performed with the extracted sub-modes using the BiblioSphere MeSH-
and GeneOntology-filter tools. Note that our method not only takes into account
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that one gene can be part of more than one pathway, but also that one pathway
can be involved in more than one cellular event. This cannot be achieved with
classical clustering tools.
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2.2.1 Signal Transduction
Within the meta-mode Signal transduction four sub-modes, 3.2, 6.2, 12.2 and 13.2
were combined together. The MAP-kinase pathway (figure 2.1) could be identified
as the major signal transduction pathway in sub-modes 3.2 and 12.2. Sub-mode
6.2 encompassed the functions signal transduction and cell communication. The
remaining sub-mode 13.2 could not be mapped to a defined pathway, but the
majority of genes within this sub-mode are associated with innate immunity and
defense functions. Among these we identified relevant genes, also related to signal
transduction, like CD86, BLNK. The transcription factors LMO2 and FLI1 were
unique in sub-mode 13.2 whereas MMP9, CD36, CTSK, C1QR1 and MYCL1 as
a TF were also present in several other sub-modes.
The 12 and 18 respectively, identified MAPK-pathway genes were all unique
within their sub-modes (table 2.1), except IL8 and DUSP1, which were present
in both sub-modes. IL8 is a member of the CXC chemokine family and thus one
of the major mediators of the inflammatory response. It is also a potent angio-
genic factor and has a signalling function in the FAS-pathway, whereas DUSP1
is assumed to play an important role in the human cellular response to envi-
ronmental stress, as well as in the negative regulation of cellular proliferation.
Another central gene of the MAPK-pathway is caspase-1 (CASP1), which was
represented in sub-mode 12.2 (figure 2.2). Caspase-1 is responsible for the matu-
ration of the multi-functional cytokine interleukin-1β and as member of the FAS
caspase cascade it is involved in FAS mediated cell death [Park et al., 2003].
Further remarkable genes associated with MAP-kinase in this sub-mode were
S100A8, S100A9, GADD45B, CTSK, SOD2 and the transcription factors JUNB
and ATF3, since they were all represented in other sub-modes or pathways, or
play a central role in the MAPK-pathway.
Sub-mode 3.2 combined the MAPK-pathway with the thioredoxin (TRX) re-
ductase/thioredoxin system. TRX is involved in a variety of oxidation reduction
reactions that regulate cell growth and survival decisions [Bishopric and Web-
ster, 2002]. It reduces ligand binding and DNA interaction by oxidizing cysteine
residues within the DNA binding domain of glucocorticoid hormone receptors.
Furthermore, TXNDC14 and TXNRD1 were found in this sub-mode. TRX also
seems to be up-regulated by NGF through MAPK1 [Masutani H, 2004]. Other
genes associated with the MAPK-pathway were: STK17A, SH3BP5, RPS6KA1,
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Figure 2.1: MAP kinase pathway analysis of the meta-modes. Yellow boxes correspond
to genes mapped to the apoptosis meta-mode, red boxes to regulatory sequences and blue
to signal transduction meta-mode, respectively. Solid arrows indicate direct and dashed
arrows indirect activation. (Detailed legend information can be found on the KEGG
website [Kanehisa et al., 2008]
CD44, G6PD, IL1RN and the transcription factors EGR2.
In sub-mode 6.2 all of the 29 genes involved in signal transduction were also
related to the MeSH-term cell communication. Five of those signalling genes
CFLAR, TXNDC1, YWHAZ, NOTCH2 and PSEN1 were also involved in the
negative regulation of cell death.
2.2.2 Regulatory Sequences
The MeSH-term regulatory sequences is described as nucleic acid sequences in-
volved in gene expression regulation. This meta-mode combines genes mapped to
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Figure 2.2: BiblioSphere pathway view shows the mapped Genes of sub-mode 12.2.
Genes passed the MAPK filter are highlighted blue. Cited relationships between two
genes make up the edges. Display of edges is restricted to those that constitute the
shortest path from the central node. If a gene that codes for a transcription factor is
connected to a gene that is known to contain a binding site for this transcription factor
in its promoter, the connecting line is colored green over half of its length near the gene
containing the binding site. Arrowheads at the ends of a connecting line symbolize that
gene X regulates gene Y.
the TP53-pathway (sub-mode 14.1) and genes related to the oncogenes JUN/FOS
(sub-mode 4.1 and 10.1), which are members of a family of transcription factors
containing the basic-region-leucine zipper or bZIP motif. The BiblioSphere soft-
ware did not define a specific pathway for sub-mode 11.2, but there were a couple
of peptidases and proteinases like LYZ, GGH and CPM as well as a remark-
able number of classical targets for the SREBP transcription factors, regulating
cholesterol and fatty acid metabolism: SQLE, CYP51A1, HMGCR, FDFT1, IN-
SIG1, IDI1, SC5DL and LDLR.
Sub-mode 14.1 represented an intersection of genes involved in gene expression
regulation and the TP53 pathway. Genes which fulfill both criteria were ADM,
CCND2, CD59, CDC42, DUSP6, GADD45A, GCH1, IER3, NDUFV2, PIM1,
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SLC2A3 and UBE3A. Moreover, sub-mode 14.1 received high significance values
(Z-Score) for the three other meta-mode categories and was also the sub-mode
with the highest amount of genes represented in other sub-modes as well. This
can be interpreted as an evidence for the complex and networked nature of gene
expression regulation and the interactivity of cellular pathways.
The transcription factor JUN also known as c-Jun belongs to the family of c-
Jun N-terminal kinases (JNKs) which are important for development and survival
of macrophages [Himes et al., 2006]. Sub-modes 4.1 and 10.1 combined twelve
genes with a known relationship to the JUN/FOS pathway: CCND2, CREM,
CXCL1, GADD45A, IL1RN, JUN, MAPK13, MARCKS, RALA, PLAU, S100A8
and SOD2.
2.2.3 Differentiation, Cell Cycle
The meta-mode cell cycle was completely governed by the TP53 pathway. Al-
though all three sub-modes 5.2, 11.1 and 12.1 represented TP53 related genes, the
intersection of genes was marginal. Only the genes DUSP6, PCNA and PRKCA
were mapped to the TP53 pathway and were also present in the sub-modes 5.2
and 12.1. Sub-mode 11.1 represented genes specialized in cell cycle pathways reg-
ulating the interphase and in particular the G1 phase, since it contained the
genes PPP1R15A, DUT, CD44, CDKN1A and SMC4L1. Sub-modes 5.2 and 12.1
mainly represented genes involved in cell growth and proliferation.
Sub-mode 5.2 was characterized by the TP53 related genes DHFR, VCAN,
APP, EIF2AK2 and the transcription factor HMGB2 and HMGB3. Here, the
latter has not been mapped to TP53 pathway but is mentioned here because of
its strong relation to HMGB2.
The unique TP53 genes in sub-mode 12.1 were: CAMK1, CTSB, GSTN1,
NME1, HMGCR, GSN, CYP51A1 and IL1RN.
2.2.4 Survival/Apoptosis
Apoptosis related pathways play a major role during the differentiation of mono-
cytes to macrophages. Here we introduce the term “survival/apoptosis” for the
MeSH term apoptosis, because the identified apoptosis pathways here function as
survival mechanisms for the differentiating cells. It has been shown, that an ab-
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sence of M-CSF induces apoptosis in cultivated monocytes [Becker et al., 1987].
Since apoptosis is regulated through many different pathways and regulatory
mechanisms, we could identify seven sub-modes (2.1, 3.1, 6.1, 8.1, 9.2, 13.1, 4.2)
related to apoptosis. These could be classified to four different pathways involved
in the regulation of apoptosis: TP53 pathway, BAX pathway, FAS-pathway and
calreticulin (CALR) regulated apoptosis. Three of these sub-modes represented
only one pathway. Sub-modes 2.1, 6.1 were mapped to the TP53 pathway and
sub-mode 4.2 is governed by CALR regulated apoptosis, whereas the others could
be mapped to more than one pathway.
Due to the strongly networked nature of biological regulatory mechanisms, a
lot of genes involved in more than one pathway can be regarded as connections
between those. Toshiyuki and Reed [Toshiyuki and Reed, 1995] showed that the
human BAX-gene is directly regulated by TP53 (TP53), whereas BAX is par-
ticipating in the regulation of endoplasmatic reticulum Ca2+ [Scorrano et al.,
2003] as well. In this way it acts as a gateway for selected apoptotic signals.
This was represented by the sub-modes 3.1, 8.1 and 13.1 which could comparably
be mapped to the TP53 and BAX pathway. Sub-mode 8.1 here combined the
most interesting combination of genes. The genes CCL3, CCND3, PAICS, FYB,
AKAB1, IL1RN, CXCL1, MT1A and the TFs EGR2 and ATF3 could be impli-
cated with BAX. These genes overlapped with five of the seven genes mapped
to the TP53 pathway: ATF3, BAX, CSPG2, EIF5B and IL1RN. Furthermore,
the metallo-thioneins which are suggested to regulate DNA binding activity of
TP53, MT1A, MT1F, MT1B and MT1X were represented in this sub-mode [Os-
trakhovitch et al., 2006].
The role of CALR as a major Ca2+-binding (storage) protein in the lumen
of the endoplasmatic reticulum is well known [Arnaudeau et al., 2002]. Conse-
quently, one might imagine that CALR is involved in the regulation of apoptotic
signals. The following genes of sub-mode 4.2 are related to CALR: SLC11A1,
CD93, PROCR, NME1 and ATP2B1. All of these genes, except ATP2B1, passed
the MeSH-filter apoptosis. The link to the TP53 pathway is the transcription fac-
tor FOXO1A (also found in sub-mode 6.1) and PRKCB1, which is also involved
in various other cellular signaling pathways.
The member of the TNF-receptor superfamily FAS plays a central role in
the regulation of programmed cell death. Sub-mode 9.2 contained eleven genes
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related to FAS: GSTM1, RALGDS, ALOX5, VCAN, S100A9, S100A8, VIL2,
LY75, STAB1, HEBP2 and CD44.
2.2.5 Otherwise Classified
Although not all sub-modes could be mapped to specific meta-modes, the re-
maining sub-modes still provide useful information. While the genes sorted to
sub-modes 7.1 and 7.2 deliver no significant pathway information, they share com-
mon behavior. Genes of sub-mode 7.1 were all down-regulated in macrophages
or up-regulated in monocytes, respectively, whereas genes of sub-mode 7.2 were
up-regulated in macrophages. Among these, known marker-genes for the different
cell types could be identified: MNDA, FCN1 and the S100 calcium binding pro-
teins S100A8, S100A9 and S100A12 as monocyte and IGF2R, TSPAN4, MMP9,
CTSK, MMD, TNS1 and CALR as macrophage genes.
Furthermore, the sub-modes 5.1, 4.1, 8.2 and 14.2 contained Major Histocom-
patibility Class (MHC) genes. Whereas the sub-mode 5.1 genes HLA-A and HLA-
C belong to MHC class I, the MHC genes of the three other sub-modes belong
to MHC class II which are: HLA-DQB1, HLA-DQA1, HLA-DPB1, HLA-DPA1
and HLA-DMB.
2.3 Conclusions
It has been stated [Liebermeister, 2002; Chiappetta et al., 2004] that the use
of ICA for the analysis of gene expression data is a promising tool, but there
is still a lack of a careful discussion of the results. Here we emphasized the
exploration of the biological relevance and obtained a detailed insight into the
networked structure of the underlying regulatory mechanisms. Two MAP kinase
related pathways could be identified as the main regulatory pathways during
differentiation: the classical MAP kinase pathway and the JNK and p38 MAP
kinase pathway, see figure 2.1. These results confirm expectations, according to
which the MAP kinase pathway is activated by the M-CSF stimulus and functions
as the main signal transduction pathway triggering macrophage differentiation
and related pathways.
The conspicuous presence of TP53 associated pathways in M-CSF induced
monocyte differentiation is associated with a dramatic regulation of cell-cycle and
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apoptosis related genes. This leads to the assumption that human mononuclear
phagocytes, which are considered to be arrested to non-proliferating cells, still
preserve proliferative potential [Martinez et al., 2006].
Furthermore, we could show that ICA is able to distinguish between monocytes
and macrophages concerning differential gene expression. This helpful attribute
can be used to find specific marker genes not only for different cell types as it is
shown here, but also for different tissues or normal and tumor cells.
Moreover, we were able to identify different regulatory mechanisms during
M-CSF dependent differentiation. Although signal transduction pathways are
mainly regulated by protein modifications like phosphorylation or acetylation,
genes associated to specific pathways involved in macrophage differentiation
could be separated into sub-modes only by analyzing gene expression signatures
and their related gene expression modes. Furthermore, this analysis could be
improved by combining gene expression sub-modes extracted from different mi-
croarray experiments into informative gene expression meta-modes. The results
are in full agreement with the experimental literature on M-CSF dependent dif-
ferentiation [Schmitz and Grandl, 2007] and illustrate the potential power of such
information-theory-based, unsupervised and data-driven analysis.
To fully explore the potential of such information-theory-based unsupervised
analysis tools and especially to determine the suitability and reliability of ICA
for the analysis of microarray datasets, further investigations are needed. The
algorithms still suffer from the fact, that the number of estimated independent
components, i.e. the extracted gene expression modes, depends on the number
of available gene expression signatures and the dimension of the related gene
expression profiles. Therefor, the availability of greater datasets should lead to
advancements, and as shown here, greater datasets can be obtained by the careful
combination of smaller datasets.
2.4 Methods
2.4.1 Dataset
For our analysis we combined the gene-chip results from three different experi-
mental settings. In each experiment human peripheral blood monocytes were iso-
lated from healthy donors (experiment 1 and 2) and from donors with Niemann-
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Figure 2.3: Histograms and expression signatures of an untransformed (A) and loga-
rithmically transformed (B) microarray expression data set.
Pick type C disease (experiment 3). Monocytes were differentiated to macrophages
for 4 days in the presence of M-CSF (50 ng/ml,R&D Systems). Differentiation
was confirmed by phase contrast microscopy. Gene expression profiles were deter-
mined using Affymetrix HG-U133A (experiment 1 and 2) and HG-U133plus2.0
(experiment 3) GeneChips covering 22215 probe sets and about 18400 transcripts
(HG-U133A). Probe sets only covered by HG-U133plus2.0 array were excluded
from further analysis. In experiment one pooled RNA was used for hybridization,
while in experiment two and tree RNA from single donors were used. The final
data set consisted of seven monocyte and seven macrophage expression profiles
and contained 22215 probe sets. After filtering out probe sets which had at least
one absent call, 5969 probe sets remained for further analysis. The complete data
set is publicly available in the NCBI Gene Expression Omnibus [Barrett et al.,
2007] through the accession number GSE9801.
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2.4.2 Preprocessing
The bulk of preprocessing has been done using the Affymetrix GeneChip Operat-
ing Software (GCOS), where default presets were used. Additionally, we applied a
logarithmic correction to the data. This has been done because effects with mul-
tiplicative behavior, which may contain biological relevant information, become
linear after logarithmic transformation. Another reason is that, untransformed
microarray expression profiles have a strongly skewed, hence unbalanced distri-
bution. This means, that there is a large amount of expression values near zero
whereas only very few genes show high expression levels (figure 2.3). To avoid
adverse effects caused by such unbalanced distributions, we applied a logarithmic
transformation. The final data are usually represented as a data matrix whose
columns represent expression signatures of N genes while the rows represent M
corresponding gene expression profiles.
2.4.3 JADE-based extraction of gene expression modes
The Joint Approximative Diagonalization of Eigenmatrices (JADE) algorithm
has been proposed by Cardoso and Souloumiac [Cardoso et al., 1993; Cardoso
and Souloumiac, 1996]. It is a nearly exact algebraic approach to perform ICA.
The algorithm JADE is based on fourth-order cumulant tensors Tz of pre-
whitened input data z = Qx given by
Cum(zi, zj , zk, zl) = E{zizjzkzl} − E{zizj}E{zkzl}
− E{zizk}E{zlzj}
− E{zizl}E{zjzk} (2.1)
with the kurtosis κ
(4)
i = Cum(zizizizi) being the corresponding autocumulant.
Associated with these cumulants is a fourth-order signal space (FOSS) which
defines the range of all mappings Tz : M→ Tz(M)
mij → [Tz(M)]ij =
m−1X
k,l=0
Cum(zi, zj , zk, zl)Mkl (2.2)
The corresponding matrices [Tz(M)]ij will be called cumulant matrices in the
following. Note that the dimensionality m of the FOSS equals at most the number
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of sources.
A spectral representation of the cumulant matrices can be obtained using the
column vectors of the whitened mixing matrix with the corresponding eigenvalues
related to the kurtosis of the independent components. This spectral representa-
tion can be used to obtain an eigenmatrix decomposition of the cumulant tensor
according to
Tz(E
(q)) = µqE
(q) (2.3)
with 0 ≤ q ≤ m2 symmetric eigenmatrices E(q) = uquTq and uq the q-th column
of the mixing matrix U, and µq being a scalar eigenvalue. After whitening, a
m × m - dimensional orthogonal matrix D = [d(0) . . .d(m−1)], which jointly
diagonalizes all eigenmatrices of Tz, is found by maximizing the joint diagonality
criterion
c(D) =
m2−1X
q=0
˛˛˛
Diag
“
DTE(q)D
”˛˛˛2
(2.4)
where Diag(.) denotes the vector of diagonal matrix elements. The joint diago-
nalizer D is then equivalent to the whitened mixing matrix U, hence the unknown
independent component expression mode can be estimated easily.
2.4.4 Sub-modes and meta-modes
As result of an ICA analysis of a set of gene expression signatures representing
the rows of the transpose data matrix XT , we obtain a matrix S of independent
components (the rows of S) which represent independent gene expression modes
(GEMs) as well as a matrix A of basis vectors of the new feature space. To de-
duce meaningful biological information from the GEMs, the discovery of specific
biological processes, which determine the modes, is the goal of our expression
mode analysis. After decomposing the data matrix with ICA, each GEM has
been split into two sub-modes which can be considered to feature genes which
are co-expressed, thus co-regulated by the underlying regulatory process. A GEM
consists of scores of gene contributions to the sub-modes which account for the
observation that excitatory as well as inhibitory regulations exist. In order to
extract the most significant genes, various statistical tools can be applied which,
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Figure 2.4: Maximum-likelihood Pearson fit of the EM-densities, for EM number 3 in
(a) and number 12 in (b). The corresponding four moments are µ(y3) = 1.4, σ(y3) = 1.0,
skewness(y3) = −0.95 and kurtosis(y3) = 4.0 for (a) and µ(y3) = −0.84, σ(y3) = 1.0,
skewness(y3) = 0.49 and kurtosis(y3) = 4.4 for (b).
however, often suffer from the small M large N case. Therefore, in most cases a
threshold is simply applied, or, after ranking, a fixed number of top and bottom
genes are chosen and further analyzed [Lee and Batzoglou, 2003]. The rational
behind these methods is that each extracted gene expression sub-mode is best
represented by its most active genes. However, the choice of threshold or num-
ber of active genes is non-trivial, and will influence the results considerably. In
this study we assume instead that mapping to distinct pathways is most non-
ambiguous by using a relatively small number of genes.
Here, we took a different approach by selecting genes that are extremal with
respect to some probabilistic model. For each GEM y(i) ∈ R, where i indexes
the genes, we calculated the first four central moments corresponding to mean,
standard deviation, skewness and kurtosis of the underlying data distribution.
These shape parameters are then used to fit a density according to the Pearson
family [Nair and Sankaran, 1991] using maximum-likelihood, see figure 2.4. We
chose a Pearson density as prior since it allows for flexible modeling with respect
to these first four moments, which seemed crucial as for example skewness varies
considerably between modes, see figure 5, and high kurtotic as well as close-to-
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Gaussian modes were present.
EM ndown nup
1 68 112
2 59 59
3 69 79
4 54 64
5 74 47
6 88 65
7 54 68
8 43 64
9 59 51
10 51 38
11 64 59
12 71 62
13 43 73
14 79 34
Table 2.2: Number of selected
down- and up-regulated genes
in each gene expression mode
(GEM).
We then used the estimated Pearson densities
to determine the 1 − α and α percentiles for
α = 1%. Samples that lie below the 1-percentile
are denoted as significantly down-regulated genes,
and genes above the 99-percentile as significantly
up-regulated genes. The corresponding sub-modes
were labeled as i.1 for down-regulation and i.2 for
up-regulation. In table 2.2 we list the number of
significant genes in each sub-mode.
2.4.5 Mode analysis
We analyzed the gene sub-modes with Biblio-
Sphere (http://www.genomatix.de). BiblioSphere
is a data mining tool intended to provide gene re-
lationships from literature databases and genome-
wide promoter analysis. The probe sets were
mapped to transcripts and to known genes with
use of the Genomatix database. To uncover the bi-
ological meaning of the genes in the sub-mode, we applied the MeSH-Filter (Med-
ical Subject Headings) to our data, which is the National Library of Medicine’s
controlled vocabulary thesaurus. We decided to use the category biological sci-
ences as filter criterion. Co-citations between the genes of the sub-mode were
taken into account by using the literature mining tool of the BiblioSphere soft-
ware. Interesting terms were identified through Z-Scores which indicate over-
representation of genes in the referring biological categories. Z-Scores are given
by Z − Score = (n − nˆ)/σn where n is the number of observed genes meeting
any given criterion, nˆ is the corresponding expected number and σn gives the
standard deviation of n. All terms mentioned in this work are significant with
respect to the Genomatix guidelines.
Depending on our filter analysis we defined several meta-modes, where we
combined sub-modes with similar categories. In some cases we subclassified sub-
modes within one meta-mode. In this way 4 meta-modes could be generated,
whereas 17 of 28 sub-modes could be mapped to at least one meta-mode. For some
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meta-modes we displaced the MeSH-Term category with additional categories
with respect to the underlying biology.
Additionally we used the KEGG pathway database for biochemical pathway
analysis to more thoroughly characterize the biological relevance of a meta-mode.
The genes corresponding to the meta-modes were mapped on database pathways
using Pathway-Express which is part of the Onto-Tools provided by Intelligent
Systems and Bioinformatics Laboratory [Draghici et al., 2007].
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3 Analyzing time-dependent microarray data
using independent component analysis derived
expression modes from human Macrophages
infected with F. tularensis holartica
3.1 Introduction
Environmental stimuli or the activity of the internal state of cells induce or
repress genes via up- or down-regulation of corresponding expressed mRNAs.
Gene expression is controlled by a combination of mechanisms including those
involving networks of signalling molecules, transcription factors and their binding
sites in the promotor regions of genes, as well as modifications of the chromatin
structure and different types of post-transcriptional regulation. The expression of
each gene thus relies on the specific processing of a number of regulatory inputs.
High-throughput genome-wide measurements of transcript levels have become
available with the recent development of microarray technology [Stekel, 2003]. In-
telligent and efficient mathematical and computational analysis tools are needed
to read and interpret the information content buried in these large data sets (see
section 1.3).
Traditionally two strategies exist to analyze such data sets. If prior knowl-
edge about classification of the samples is available, a supervised, also called
knowledge-based, analysis can identify gene expression patterns, called features,
specific to a given class, which can be used to classify new samples. Without any
hypothesis, unsupervised, i.e. data driven, approaches can discover novel biolog-
ical mechanisms and reveal genetic regulatory networks in large data sets. Such
unsupervised analysis methods for microarray data analysis can be divided into
clustering approaches, model-based approaches and projection methods. Clus-
tering approaches group genes by some measure of similarity. A fundamental
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assumption of such clustering approaches is that genes within a cluster are func-
tionally related. In general, no attempt is made to model the underlying biology.
A drawback of such classical methods is that clusters generally are disjunct but
genes may be part of several biological processes. Model-based approaches try to
explain the interactions among the biological entities with the help of hypoth-
esized concepts. Parameters of the model can be trained from expression data
sets [Friedman, 2004]. With complex models not enough data may be available
to properly estimate the parameters, hence overfitting may result. Projective
subspace methods try to expand the data in a basis with desired properties.
Projective subspace methods commonly used are principal component analysis
(PCA), independent component analysis (ICA) or non-negative matrix factor-
ization (NMF). Note that often PCA is a necessary preprocessing step for ICA
algorithms. Here we focus on the well-known stochastic FastICA algorithm to
analyze our time-dependent gene expression profiles (GEPs).
ICA decomposes the GEPs into statistically independent gene expression modes
(GEM), the so-called independent components (ICs) [Cichocki and Amari, 2002].
The algorithm FastICA assumes a linear superposition of these unknown GEMs,
also called source signals, forming the observed GEPs measured with microarray
gene chips. Each retrieved GEM is considered to reflect a basic building block
of a putative regulatory process, which can be characterized by the functional
annotations of the genes that are predominant within the component. Each GEM
thus defines corresponding groups of induced and/or repressed genes. Genes can
be visualized by projecting them to particular expression modes which help to
highlight particular biological functions, to reduce noise, and to compress the
data in a biologically meaningful way.
In this work microarray data of human macrophages, deduced from human
monocytes by M-CSF triggered differentiation and infected with a F. tularensis
holartica strain called LVS (live vaccine strain), were analyzed. Our aim was to
determine the global gene expression profile of human macrophages from three
different donors infected in vitro with F. tularensis LVS. Expression profiles were
followed over a period of 72h, resulting in a series of ten experiments. To mon-
itor assay and hybridization performance, a set of quality parameters (poly-A
controls, hybridization controls, percent present, background and noise values,
scaling factor) were assessed. None of them exceeded the given ranges, indicat-
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ing that our data is of high quality. An analysis of these experiments using the
FastICA algorithm [Hyva¨rinen, 1999] is reported in this work.
3.2 Methods
3.2.1 Sample preparation and expression level calculation
Human monocytes were obtained from three healthy donors by diagnostic leuka-
pheresis and counterflow elutriation as described previously [Langmann et al.,
2003] under full GLP (good laboratory practice) conditions. The cells were cul-
tured on plastic petri dishes in macrophage SFM medium (Gibco BRL, Karl-
sruhe) and allowed to differentiate for 5 days in the presence of 50 ng/ml recom-
binant human M-CSF (R&D Systems, Wiesbaden, Germany) to macrophages.
Finally, the cells were infected with F. tularensis LVS. Three independent F. tu-
larensis LVS infection experiments were chosen for further analysis. The infection
rates and the percentage of living cells were comparable in all three experiments.
Total RNA was extracted from cultured cells according to the manufacturer’s
instructions using the RNeasy Protect Midi Kit (Qiagen, Hilden, Germany). Pu-
rity and integrity of the RNA was assessed on the Agilent 2100 bioanalyzer with
the RNA 6000 Nano LabChip® reagent set (Agilent Technologies, USA). The
RNA was quantified spectrophotometrically and then stored at -80 ◦C. At each
timepoint enough total RNA could be isolated for DNA-microarray analysis and
subsequent realtime RT-PCR verification experiments. The quality assessment
of RNA samples is a major point in DNA-microarray analysis. All RNAs were
of superior quality without any signs of mRNA degradation. The RNA integrity
number (RIN) was close to the optimum (10) in all experiments.
Gene expression levels were measured using Affymetrix GeneChip® HGU133
Plus 2.0 Arrays. Array comparison analysis was carried out by calculating ex-
pression levels and fold changes using Affymetrix GeneChip Operating Software
(GCOS). Expression values after 0.5h, 1h, 2h, 3h, 6h, 9h and 12h of incubation
with 100 MOI (multiplicity of infection) F. tularensis LVS were compared to the
1h control incubation. Furthermore, infected and control probes were compared
after incubation at 24h, 48h and 72h.
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3.2.2 Model assumptions
The transcription level of all genes in a cell is the result of the action of several
regulatory processes which in parallel control the response of a cell to external
stimuli. Matrix decomposition techniques set out to factorize a set of observed
GEPs into components according to some specified constraints to assure unique
decompositions. Such constraints then lead to either statistically uncorrelated
(PCA) or even statistically independent (ICA) components. The latter may of-
ten be identified as regulatory processes governed by signalling pathways which
are only weakly coupled to each other and can be considered as acting indepen-
dently of each other to a first approximation. Each such process can then be
represented by a vector of expression levels of up- or down-regulated genes, the
gene expression modes (GEMs). Under each experimental condition, the differ-
ent regulatory processes then linearly superimpose the expression levels of each
gene according to the different GEMs to result in the observed GEPs measured
by a microarray sample. The justification of such simplifying assumptions comes
from the ”biological meaning” of the resulting expression modes extracted by
such matrix decomposition techniques. If such GEMs can clearly be identified
with known signalling pathways within a cell for the problem at hand, the model
decomposition is justified. Otherwise non-linear decompositions might need to
be considered. For such matrix factorization algorithms to be applied, centered
data, i.e. 〈x〉 = 0, will be assumed for simplicity. This can always be achieved by
subtracting a time averaged expression level from each data point.
3.2.3 ICA model
Given the state of a cell at the time of experiment is governed by M regulatory
processes S = (s1, . . . , sM )
T which are considered reasonably independent of
each other and operate in parallel, and where each of them is represented by a
row vector of K gene expression levels, i.e. sm = (sm1, . . . , smK), then S forms
a M × K matrix whose rows consist of statistically independent GEMs. Each
such mode forms a component expression pattern or component signature, in
which the contribution of each gene to the envisaged independent regulatory
processes is reflected via its expression level. Within a microarray experiment,
the level of expression of all genes xn = (xn1, ...., xnK) is measured under N
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different experimental conditions, resulting in a microarray expression matrix
X = (x1, . . . ,xN )
T , where the rows form the GEPs xn. Hence, a microarray
data matrix X can be formed with N rows, representing GEPs, and K columns,
representing the expression levels of a gene across all experimental conditions.
Assuming that different experimental conditions cause different expression levels
of each gene within the independent regulatory processes, each observed GEP,
i.e. each row of X, results as a weighted superposition of the independent GEMs,
represented by the rows of S. In matrix notation this model then reads
X = APDS, (3.1)
where A represents the N ×M matrix of mixing coefficients and here we set
N = M . The under-determined or over-determined cases with N 6= M is more
difficult and will not be considered here. The N columns of A may be considered
to form a new representation with basis vectors am = (am1, . . . , amN ), also called
feature profiles (FP), where each amn defines the weight with which the nth GEM
contributes to the mth observed GEP. In addition, the matrices P and D account
for trivial permutation and scaling indeterminacies.
By approximating the negentropy as a measure of statistical independence, the
FastICA algorithm computes a de-mixing matrix W such that
Y = WX, (3.2)
where Y represents a matrix of transformed variables y1, . . . ,yN , which cor-
respond to the extracted independent components or GEMs subject to scaling
(D) and permutation (P) indeterminacies [Comon et al., 1994]. They are ex-
tracted from the data by the algorithm as statistically independent as possible,
and represent close approximations of the unknown expression signatures of the
hypothetical underlying regulatory processes represented by s1, . . . , sN .
3.2.4 Stability Analysis
The number of GEMs extracted by the FastICA algorithm corresponds to the
number of experiments, i.e. the number of different microarray data sets avail-
able. As the number of underlying independent regulatory processes contributing
to any observed set of expression signatures is generally unknown, the GEMs
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Figure 3.1: The means and the standard deviations of the differences d of all clustered
row vectors w ∈ W to the corresponding code book vector cp for each independent
component (IC) compared to a null model of randomly sampled clusters.
extracted, due to the independence constraint enforced by the data matrix de-
composition, may, at least to some extent, still represent superpositions of such
underlying regulatory processes being searched for. This fact results in fluctu-
ations in the estimated GEM upon repeated decomposition of the given data
matrix. Unfortunately, these fluctuations also sometimes confounds the imme-
diate and straightforward biological interpretation of such modes. Despite this
it is the hope of every matrix decomposition analysis that the resulting GEMs
provide for a more intuitive and insightful interpretation of the observed states
of the cell under the experimental conditions and environmental stimuli to which
it was exposed.
Because FastICA belongs to the class of stochastic matrix decomposition algo-
rithms, the robustness of its results needs to be assured. To test the robustness of
the resulting GEMs, we performed a bootstrap analysis. To do so, we randomly
generated 50 sub-samples with a sample size 25% smaller than the original data
set. As a consequence, repeating the analysis L = 50 times might render some or
all of the extracted components to differ slightly in the various repeats. We then
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estimated the robustness of these repeatedly extracted GEMs.
We combined the rows wln to a set W of row vectors, where l represents a
particular ICA run and n is the nth row of the de-mixing matrix Wl. Because
W = A−1 each row vector wn contains the weights with which each observed
GEP is combined to an extracted GEM. Using a projective k-means clustering
[Gruber et al., 2006] the resulting row vectors are then clustered into N clusters
according to the following metric representing our distance or similarity measure:
d(w,v) :=
vuut1− wTvp‖w‖‖v‖
!2
w,v ∈ W (3.3)
.
Now we use the centers of gravity of each cluster as code book vectors cn, n =
1, . . . , N for our stability analysis. The result of the clustering can be described
by the sets Wn = {w ∈ W | s(w) = cn} with s(w) = arg minn d(w, cn).
We evaluated the quality of each cluster Wn by calculating the 1st and 2nd
moment of the distance distribution within each cluster, i.e. the empirical mean
and standard deviation of all distances between the code book vector cn of
cluster n and the data vectors within the cluster using the distance measure
d as defined above. In particular, meann = mean({d(w, cn) | w ∈ Wn}) and
varn = var({d(w, cn) | w ∈ Wn}) (figure 3.1). As a null model we randomly
sampled N clusters from W with size L. For each sampled cluster we calculated
the mean and standard deviation of all distances between the sampled vectors
and the respective projective centroid.
3.2.5 Grouping genes
Each estimated GEM contains the gene expression levels of all genes within any
given microarray experiment, i.e. every experimental condition chosen. Assuming
that the genes involved in a hypothetical regulatory process represented by the
GEM show relatively high expression within this GEM, then those genes are of
utmost interest which correspond to the most or the least expressed. Only genes
whose expression level exceeded the mean expression level plus five times the
standard deviation of the considered GEM were retained for further analysis.
These genes have been grouped together into gene groups of size between 35 and
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94 genes, containing the most strongly expressed or suppressed genes. Remember
that one gene may be involved in more than one regulatory process, i.e. its
expression level may be high or low in several gene expression modes.
3.2.6 Biological relevance
Further information about the biological relevance of the genes and their regula-
tion mechanisms can be gathered from public databases such as Gene Ontology
(GO) (available at http://www.geneontology.org/). The biological information
available within GO can be further explored using software tools like Onto-
Express [Draghici et al., 2007] (available at http://vortex.cs.wayne.edu/Projects.
html) or Genomatix BiblioSphere (see http://www.genomatix.de/).
BiblioSphere provides further biological information by structuring input data
into biological pathways, i.e. networks of interacting genes thereby delivering
systems biology knowledge to organize genes within groups into functional net-
works. The interaction network is a data-mining solution in which relationships
from literature databases, genome-wide promoter analysis and verified gene in-
teractions are combined. Results can be classified by tissue, Gene Ontology and
MeSH (see http://www.nlm.nih.gov/mesh/).
Statistical rating by Z-scores indicate over- and under-representation of genes
in the certain biological categories which are organized into hierarchies. For each
term in the hierarchy, a statistical analysis is performed based on the number
of observed and expected annotations. With each associated GO or MeSH term
a Z-score is provided measuring the relevance of the functional term within the
context of the group of genes under consideration. Z-scores are given by Z-score
= (n − nˆ)/σn, where n is the number of observed genes meeting any given
criterion, nˆ is the corresponding expected number and the standard deviation
σn measures the fluctuations of n around the mean. The Z-score of this term
helps to estimate whether a certain annotation, or group of annotations, is over-
or under-represented in the tested set. Such score helps to determine whether the
accumulation of annotations in a certain branch of the hierarchy is meaningful.
72
Figure 3.2: Functional gene networks resulting from a hierarchical clustering analysis.
Expression levels for each gene are color-coded. Overexpression is colored red, under-
expression blue. The stripes from left to right code for early, middle and late response.
Cited relationships between two genes make up the edges. Display of edges is restricted
to those that constitute the shortest path from the central node. If a gene coding for a
transcription factor is connected to a gene with a predicted binding site in its promoter,
the connecting line is colored green over half of its length near the target gene. Arrow-
heads at the ends of a connecting line symbolize regulation. Hand-annotated gene-gene
relationships are indicated by a circle in the center of the connection line.
3.3 Results
3.3.1 Pathways biostatistics
For a knowledge-based pathway analysis, all expressed genes from the three LVS
infection experiments were mapped to 78 manually annotated biomedical path-
ways. To avoid a proband specific bias and to determine a global expression pro-
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file, only those genes were retained which displayed similar responses (up-/down-
regulation) in all three probands across all measurements. This analysis resulted
in 54 genes (52 induced genes, 2 repressed genes) indicating that Chemokine sig-
naling, interleukin 1 and TNF-response as well as NFκB signaling are the major
pathways strongly influenced by LVS. Prostaglandin synthase 2 and superoxide
dismutase 2 are also induced. Lysophospholipase 3 and zinc finger protein 589
are the only repressed genes detected.
3.3.2 Hierarchical clustering
As a further analysis method, we performed a hierarchical clustering on the data
set and selected clusters of differentially expressed genes which show similar time
dependent behavior over all three donors. This resulted in 3 clusters correspond-
ing to an early (35 genes), a middle (54 genes) and a late (89 genes) response.
Resp. MeSH Term Z-score Percent.
ER Inflammation 53.03 31%
ER Sepsis 24.32 26%
ER Systemic Inflammatory Response Syndrome 22.97 26%
ER Reperfusion Injury 20.86 14%
ER Shock 18.31 20%
MR Inflammation 22.6 9%
MR Cell Transformation, Neoplastic 14.45 17%
MR Cell Transformation, Viral 10.26 7%
MR Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Assoc. 9.56 2%
MR HTLV-I Infections 8.85 2%
LR Leukemia, Promyelocytic, Acute 155.37 9%
LR Leukemia, Nonlymphocytic, Acute 81.32 12%
LR Leukemia, Myeloid 65.03 15%
LR Leukemia 52.06 18%
LR Translocation, Genetic 42.02 7%
Table 3.1: Terms and Z-scores resulting from a hierarchical clustering and MeSH filter-
ing. ER = early response; MR = middle response; LR = late response. Also the fraction
of the genes associated with each MeSH term is given in %
To further define the regulatory network between these genes and to search for
interdependent activation waves, Genomatix BiblioSphere analysis was carried
out with these data sets. Functional analysis based on the MeSH Filter “Disease”
resulted in the following top five terms with good Z-scores for each of the three
response terms (table 3.1). To gain a focused view on a disease related network,
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genes related to the top terms of each cluster were combined. This resulted in
a network of 49 genes which was analyzed again using BiblioSphere (figure 3.2).
The corresponding regulatory network is centered around TNF. As can be seen,
the expression levels of genes encoding TNF, as well as TNF-interacting pro-
teins like (TRAF1, TNFAIP8), adhesion molecules (ICAM1) and kinases increase
rapidly and decline at later times thus representing an early response. At these
early times, signal transducer and activator of transcription genes (STAT1/2)
are predominantly weakly expressed. In a second signaling wave, the expression
levels of TNF induced genes such as the transcription factor NFκB (NFκB1,
NFκB2, NFκBIA) and their target genes (IRF7, NUP98, MAPK3K8) increase
during an intermediate time interval representing a middle response. During a
final late response, TNF expression declines and expression of the concomitant
signaling genes decreases (NFκB1/2, Rel). Late cytokine response, represented by
the interferon-induced proteins (IFI2/3, MX1/2), is continually increased during
the kinetic experiment. An overlap between these regulatory models and the top
54 genes from the pathway analysis concerning inflammation associated genes
like ICAM1, IRAK2, JAG1, NFKB1, NFKB2, TRAF1 and TNF is observed.
3.3.3 ICA analysis
As a result of the ICA analysis, we obtained N = M expression modes which
represent the hypothetical gene regulatory processes. To identify relevant pro-
cesses represented by the extracted GEMs, we analyzed time dependent patterns
formed by the FPs setting up the mixing matrix A. To avoid a proband spe-
cific bias we filtered out FPs similar among all three probands. Therefore we
split up each FP into proband specific temporal patterns and compared them by
calculating correlations. Only those FPs which show a high correlation (above
0.8) between all probands specific patterns were used for further analysis. To
find FPs comparable to the clusters derived by the hierarchical clustering ap-
proach, we identified those with temporal patterns showing high early, middle or
late response activity (figure 3.3). We have chosen three FPs for each response
type respectively, and merged the extracted gene groups from the corresponding
GEMs to three response groups (RG) called early (149 genes), middle (171 genes)
and late (158 genes).
The biological relevance of these RGs was explored using the Genomatix soft-
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Figure 3.3: Feature profiles with similar temporal patterns for all three probands
(Prb 1-3). Blue, green and red bars. Shown are only those, used for time dependent
response analysis: top: early response, middle: middle response, bottom: late response.
Gene response groups were created from the corresponding gene expression modes. See
text for a detailed explanation.
ware. We analyzed each RG using the MeSH Filter “Disease”. This resulted in a
list of the most related MeSH terms (see table 3.2). They are strikingly different
to the MeSH terms derived from hierarchical cluster analysis, and in accordance,
the ICA derived terms show noticeably higher Z-scores (Inflammation, Systemic
Inflammatory Response Syndrome). Furthermore, ICA results show Inflamma-
tion as the highest ranked term in all three responses. The percentage of genes
associated to MeSH-terms is consistently higher in ICA derived RGs.
The additionally derived network can be seen in figure 3.4. The early response
is largely governed by the pro-inflammatory cytokines (TNF, IL13, IL1B) and
chemokines (CXCL2, CXCL3, CXCL5, CCL2-5, CCL8) as well as up-regulation
of NFκB. This is followed by activation of TNFα and NFκB induced proteins like
TRAF1, MMP9 and the major histocompatibility complex proteins HLA-DRB1,
HLA-A and HLA-B. During late response, again the activity of the chemokines
CXCL1 and CXCL5 were discovered, as well as the IL8 related genes MRC1,
MX1 and CCL18. Here again, the accordance to the 54 top regulated genes
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Figure 3.4: Functional gene network resulting from the ICA analysis. Stripes from left
to right code for early, middle and late response group. If a gene is a member of one or
more of the response groups the stripe is colored red. Edges between two genes denote
co-occurrence within one abstract. Display of edges is restricted to those that constitute
the shortest path from the central node. ’TF’ stands for transcription factor, ’ST’ means
gene is part of Genomatix signal transduction pathway, ’IN’ means input gene and ’M’
marks a gene which is part of a metabolic pathway.
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Response MeSH Term Z-score Percentage
ER Inflammation 93.74 52%
ER Bacterial Infections and Mycoses 49.36 48%
ER Arthritis 44.51 40%
ER Joint Diseases 43.63 40%
ER Systemic Inflammatory Response Syndrome 42.95 33%
MR Inflammation 64.35 49%
MR Bacterial Infections and Mycoses 30.61 40%
MR Systemic Inflammatory Response Syndrome 27.35 23%
MR Sepsis 25.69 21%
MR Arthritis 24.78 33%
LR Inflammation 46.98 47%
LR Arthritis 27.7 40%
LR Joint Diseases 27.22 41%
LR Rheumatic Diseases 26.15 41%
LR Gram-Negative Bacterial Infections 24.66 30%
Table 3.2: Terms and Z-scores resulting from an ICA analysis and MeSH filtering. ER
= early response; MR = middle response; LR = late response. Also the fraction of the
genes associated with each MeSH term is given in %
is striking through a complete overlap of the associated highest ranked MeSH
Terms: “Inflammation”, “Arthritis”, “Joint Diseases”, “Bacterial Infections and
Mycoses” and “Systemic Inflammatory Response Syndrome”.
A further attribute of ICA based analysis is the grouping of genes into non-
exclusive clusters. Hence, genes influencing more than one specific process can
be found in more than one RG. Some of those interesting genes are the cytokines
IL1B and IL8 or the surface protein coding genes CD36 and CD44 which were
identified as presumably key players for gene regulatory networks involved in
LVS infection response.
3.4 Discussion
Using the data-driven ICA approach, additional novel pathways were identified
in addition to pathways similar to the ones deduced from classical hierarchical
clustering approaches. Among the early responders, the pro-inflammatory cy-
tokines TNFα and CCL2 were induced, which confirm previous findings about
the secretion of large amounts of these inflammatory cytokines in a similar in
vitro model using murine macrophages and human cell lines [Loegring et al.,
2006]. Furthermore, in a murine macrophage cell line model, testing immediate
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responder genes by microarray analysis within the first 4 hours after infection
with F. tularensis LVS, TNFα was found to be the main signal transducer whose
expression level was found to be increased along with genes representing cytokine
signaling-, enzyme- and transcription factor-families [Andersson et al., 2006]. The
differences observed between our early responder genes and the immediate re-
sponders found in the murine model system emphasize the need of a multi-time
point kinetic model of macrophage response to F. tularensis LVS infection with
a well established microarray analysis method.
The virulence of F. tularensis depends on its ability to escape into the cytosol
of the host cell, which reacts with the assembly of the caspase-1 dependent in-
flammosome complex. This process is closely related to the secretion of IL1b,
IL18 and IL33, by which the induction of IL1b was also found with our analysis
[Henry and Monack, 2007]. Recently, a natural killer (NK) cell cytokine, IFNγ
dependent activation pathway was found to be relevant for the specific immune
response to F. tularensis LVS infection [Lo´pez et al., 2004]. We found a significant
up-regulation of the IFNγ receptor 2 in macrophages, which in turn sensitizes
these cells for the NK-cell derived IFNγ to result in a specific response.
These data show that, with the help of in vitro model systems using microarray
analysis, the mechanism of F. tularensis LVS response can be well characterized
and disease specific pathways discovered and identified. Moreover we could show
that NFκB plays a major role regulating the immune response to F. tularensis
LVS infection.
In comparison to the commonly used hierarchical clustering method, we found
that our calculations using ICA resulted in higher clustering resolutions. The
response specific MeSH terms derived through an ICA analysis are more closely
related to the experiment (Bacterial Infections and Mycoses, Gram-Negative Bac-
terial Infections) and all three response groups show Inflammation as the most
highly ranked MeSH term. Moreover, the nonexclusive clustering attribute of
ICA leads to a more detailed insight into time-dependent patterns of the im-
mune response.
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4 Intronic microRNAs support their host genes
by mediating synergistic and antagonistic
regulatory effects
4.1 Introduction
Gene regulation via microRNAs (miRNAs), small ∼22 nucleotide long RNA
molecules, is a strongly conserved mechanism found in nearly all multicellular
organisms including animals and plants [Carrington and Ambros, 2003]. Incor-
porated in a protein complex mainly built of Argonaute proteins, miRNAs bind
preferably to complementary regions within the 3‘ UTRs of mRNAs, their target
sites. About 37% of known mammalian miRNAs are located within the introns of
protein coding genes, so-called host genes [Griffiths-Jones et al., 2006]. This has
to be appreciated as a vague estimate since the amount of annotated miRNAs
varies strongly from 117 for bos taurus to 695 for homo sapiens, and expectations
of the functionally active fraction of the genome presumes amounts of miRNAs
far above these numbers [Pheasant and Mattick, 2007; Birney et al., 2007]. For
instance, the proportions for mouse (44%) and human (53%), two of the best
studied mammals, were strikingly larger. Furthermore, intronic miRNAs appear
to be conserved across several species [Ying and Lin, 2005; Rodriguez et al.,
2004; Saini et al., 2008]. These miRNAs are transcriptionally linked to their host
gene expressions and processed from the same primary transcript [Baskerville
and Bartel, 2005]. Besides Drosha-processed miRNAs, a second type of intronic
miRNAs, termed mirtrons, is known, that bypass Drosha cleavage by splicing
[Ruby et al., 2007; Chan and Slack, 2007] but exhibit the same co-expression
patterns with their host genes.
In animals, and more recently also in plants, it has been found that exact
complementarity of target sites is not required for functional regulation. Unlike
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perfect matching, which leads to cleavage of the mRNA, partial complementarity
of the target mRNA mainly leads to inhibition of ribosomal translation. How-
ever, due to the noncatalytic character of the miRNA-mediated regulation, both
mechanisms have similar inhibitory effects [Levine et al., 2007]. MiRNA-mediated
gene regulation can be categorized into ‘switch’, ‘tuning’ and ‘neutral’ [Bartel,
2004, 2009] effects. Switch regulation describes a knock-down of protein levels
under a specific functional threshold caused by effective translational inhibition
or cleavage of the target mRNA. In contrast, tuning does not inhibit target ac-
tivity completely but tunes expression in a way such that miRNA targets are
adjusted to a specific expression level required under specific cellular conditions.
By neural targets one denotes miRNA-mRNA interactions, that are functional
but without any advantageous nor adverse consequences to the cell. Since the
neutral regulation does not have any effect on the phenotype, it will further on
not be discussed in this work. MicroRNA-mediated regulatory mechanisms are
known to appear in animals from early developmental stages to maturated adult
tissues. They play a role in a variety of biological processes including cell differ-
entiation, stem cell maintenance, proliferation as well as regulation of apoptosis
[Stefani and Slack, 2008; Hwang and Mendell, 2006].
It is a common paradigm in biology that conservation on the genome level also
implies a conservation of function. Therefore we hypothesize that the widespread
appearance of the transcriptional junction of a protein coding gene and the reg-
ulatory miRNA implies a common function. Specifically, the co-regulation of a
miRNA with its host gene may include two different main functions: (i) An an-
tagonistic effect is achieved by miRNA mediated downregulation of genes with
perturbing effects on a pathway or biological process activated by the host gene.
The combined expression of an effector gene and a miRNA, which blocks trans-
lation of such antagonistic gene products, is a simple but elegant way to promote
and support host gene functionality (Figure 4.1A). (ii) A synergistic effect is
achieved by adjusting the protein expression levels of intronic miRNA targets
towards intended optimal concentrations. A specific ratio between host and tar-
get gene products then allows for effective and optimized cooperative actions of
co-regulated genes (Figure 4.1B). In humans, a functional relation between the
host gene GRID1 and the intronic miR-346 has been shown recently [Zhu et al.,
2009] and the here proposed antagonistic effect has been proven for the intronic
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Figure 4.1: The two proposed regulatory mechanisms of functional host to miRNA
relationships. Genes are marked by ellipses, miRNA by rounded rectangles. Host miRNA
relations are indicated by an edge with a dot. MicroRNA target regulation is indicated
by a blank triangle. A minus denotes knock down of the target gene, whereas tilde
denotes regulatory tuning. Activating effects on a biological process is shown by an
arrowhead, inhibition is indicated with stops. Expression is color coded, co-expression
is indicated green and anticorrelated expression red.(A) An antagonistic effect can be
achieved by miRNA mediated downregulation of a gene with perturbing effect on a
pathway or biological process regulated by the host gene. (B) Synergistic effect by
miRNA mediated fine tuning of a target gene with common contribution of host and
target gene to a pathway or biological process.
miR-338 and its host gene AATK [Barik, 2008].
In this work, we investigated the functional relation between miRNA host
genes and putative targets of corresponding intronic miRNAs with a data-driven
approach based on large-scale gene expression data and a knowledge-based ap-
proach using gene annotations. Genes sharing a common function, such as being
involved in the same biological pathway, tend to share similar regulatory mech-
anisms and therefore appear as co-expressed genes in their expression profiles
[Allocco et al., 2004]. Thus, genes with correlated time-dependent expression
patterns are likely to be involved in functionally related cellular processes with
synergistic effects. In contrast, anticorrelated expression pattern would promote
the assumption that the participant genes take part in related, but antagonistic
processes. Furthermore, functional gene annotations as provided by the Gene
Ontology (GO) [Ashburner et al., 2000] give information about a common or
strongly related function of two genes, for instance hosts and targets. We hypoth-
esized that functional relations between miRNA host genes and related target
genes appear in significant correlated expression patterns and we expected, that
host and target gene sets are closer related in the GO as randomly sampled sets,
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for both antagonistic and synergistic motifs as introduced in figure 4.1.
4.2 Results and Discussion
4.2.1 Targets of similarly expressed host genes show correlated
expression patterns
We studied the relationship between host and target genes, in three different
mouse developmental microarray datasets (see methods): embryonic stem cell de-
velopment (SCD), somitogenesis (SG) and neurite outgrowth (NO). We chose de-
velopmental datasets since regulatory effects of miRNAs are known to be strongly
present in developmental processes [Gangaraju and Lin, 2009]. During cell dif-
ferentiation, groups of genes driving specific developmental processes are often
commonly regulated, arising in the phenotypic effect of similar expression pat-
terns of these genes in time course data. A synergistic relationship between host
and the miRNA target genes of differentiating cells is then indicated by posi-
tively correlated gene expression patterns. In reverse, antagonistic processes are
expected to show anticorrelated or weakly correlated expression patterns between
host and related target genes.
Since we argue that correlated expression indicates for potential common host
gene functions, we initially tested for correlations between host gene expressions.
In order to generate statistically robust results, independent of data and pre-
diction errors, we did not analyze single gene expression patterns but argue on
groups of correlated genes. Therefore, for each dataset we identified all miRNA
host genes and clustered their time courses according to correlations above 0.8
(see methods). Within all analyzed cell differentiation datasets, host genes tend
to be co-expressed in clusters. As a result of our clustering we obtained seven
host gene clusters with more than 5 host genes (see table 4.1).
Intriguingly, some host genes appear to be clustered together preferentially
across the experiments. The genes H19, Igf2, Lpp, Plod3, and Rnf130 were clus-
tered together in the two clusters SCD I and NO I, and the genes Chm, Copz1,
Dnm1, Nupl1, and Sf3a3 together in the clusters SG I and NO II.
For each host gene cluster we identified the intronic miRNAs and all their
expressed targets. Most prediction tools for miRNA target site prediction vary in
qualitative and quantitative manner. In order to get more confident predictions,
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Figure 4.2: Clustered heat maps for the seven host gene cluster (H) and the corre-
sponding target gene expression profiles (T). For all three time course datasets only
clusters with more than five host genes are shown. Each row corresponds to one gene
expression pattern, each column to a measurement. Time dependent measurements are
shown in ascending order from left to right. The expression level of each gene is stan-
dardized so that the mean is set to 0 and the standard deviation is 1. Expression levels
above and below 0 are color-coded; red indicated for high and green for low expression
levels, respectively; black for zero expression values. Biological replicates of the three
datasets are in order from Rep. 1 to Rep 2 and Rep. 3, respectively. Hierarchical cluster-
ing with euclidean distance metric and average linkage is used. Colored subtrees in the
dendrogramm denote for co-expressed (green) or anticorrelated (red) gene expression of
predicted targets. (Somitogenesis) The dataset splits up into three host gene cluster,
SG I with 13, SG II with 21, and SG III with 7 host genes. (Neurite Outgrowth)
Two cluster with 10 (NO I) and 17 (NO II) host genes could be identified with similar
behaviour of host and target genes in both replicates. (Stem Cell Development) Two
host gene clusters containing 9 (SCD I) and 8 (SCD II) hostgenes were identified. All
host and target genes show similar behaviour in all three replicates. For each dataset,
flipped expression patterns between the host/target clusters are striking (SG I vs. SG
II; NO I vs. NO II; SCD I vs. SCD III). 85
we used a consensus model (C) of several miRNA target prediction tools (see
methods). A detailed list of all analyzed miRNAs/clusters in this work including
host genes, loci, a correlation and a GO similarity based score is available as
Supplementary Table 1.
For the seven clusters we performed a hierarchical cluster analysis based on the
expression data of the target genes (see Figure 4.2). All resulting trees mainly
split up in two subclusters: one subcluster of genes with similar or positively
correlated expression patterns and one with opposing or anticorrelated expression
compared to the host genes, respectively. Furthermore, within each dataset, the
resulting trees of at least two target gene groups appeared to show completely
flipped expression patterns of the main subclusters (SG I vs. SG II; NO I vs. NO
II; SCD I vs. SCD III).
These results fit well to the observation that miRNAs dampen the output
of preexisting mRNAs or optimize required protein output as it is proposed
for metazoans [Bartel and Chen, 2004]. Additionally, in [Farh et al., 2005] it
was shown that genes preferentially expressed at the same time and place as a
miRNA tend to avoid sites matching the miRNA. By contrast, co-expression of
a transcripts with evolutionary conserved miRNA binding site would then arise
from a functional requirement.
The clear discrimination between the two expression patterns suggests a grad-
ual order of differentiating cells, whereas miRNAs function as enhancers of ro-
bustness in gene regulation [Rhoades et al., 2002; Tsang et al., 2007]. A plausi-
ble explanation would be that shortly after initiation of the differentiation pro-
cess, genes that arrange the differentiating cell towards its new function are
up-regulated. In this stage miRNAs are activated to inhibit processes required
for self-renewal of stem cells but were perturbed during differentiation. After this
‘reprogramming’ the cell adopts new functions and stabilizes. In this phase genes
are up-regulated which now fulfill the cell’s new responsibilities and simultane-
ously block activity that was only required for differentiation.
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Figure 4.3: Results of the host gene cluster based expression analysis. Grey bars denote
the number of all identified host gene clusters including unclustered hosts with expressed
target genes, predicted by Pictar (PT), TargetScan (TS) and our consensus model (C).
Orange bars denote the number of clusters with significantly correlated target gene
expression patterns. The relative fraction of significant clusters for each dataset and
miRNA target prediction tool is denoted.
4.2.2 MicroRNA host gene cluster and related target genes show
significant correlations of their expression patterns and
functional similarities
In order to confirm the above observed and to show statistically that gene ex-
pression patterns of host genes are significantly correlated with the patterns of
their predicted target genes, we determined the correlation distribution for each
cluster by calculating correlation coefficients between all hosts and all expressed
putative target genes. These distributions were compared to 500 sets of randomly
sampled target genes (see methods). To avoid any bias by our consensus model,
we additionally used two further independent prediction tools, namely Pictar
(PT) [Krek et al., 2005] and TargetScan (TS) [Lewis et al., 2003]. For each host
gene cluster and each single host gene, expression patterns were compared to ex-
pression of predicted targets. Only clusters with predicted and expressed targets
in the respective dataset were used in the following analyses.
Results can be seen in Figure 4.3. Concordant for all used methods and all
analyzed datasets, we determined that up to 44% of the identified host gene
clusters were significantly positively correlated or anti-correlated to their target
gene expressions. Comparing the the three datasets, we only found marginal
differences. The average amount of host gene clusters with significant correlated
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Figure 4.4: As an example, figure(A) shows the distributions of correlation coefficients
ρ between host and target gene expression patterns (blue) of Cluster NO I and corre-
lation coefficients ρ between the same host genes and sampled target genes (red). The
medians are illustrated by blue and red lines, respectively. ∆m indicates the difference
between the two medians. A missing relation between host and target gene expression
would result in a difference ∆m = 0. The distributions of ∆m taken over all significant
clusters of the three datasets are shown in the two histograms for targetscan (B) and
our consensus model (C). Estimated densities of positive and negative ∆m distributions
indicating for antagonistic or synergistic regulatory effects are shown by the orange and
green line. Missing distances of ∆m = 0 in both distributions indicate that all sig-
nificant clusters deviate from the null model (sampled data). Both distributions show
bimodal shape with equal maxima on both sides, indicating that positive and negative
correlations are approximately equally distributed over all analyzed clusters.
target expression varies between 27% and 30%.
Comparing the three tools, PT performs strikingly weaker (15%) than TS
and the consensus model with regard to the mean fraction of host gene clusters
with significant correlated predicted target expressions (37% and 34%). Since the
number of targets predicted with PT for each host gene is in average considerably
smaller compared to the two other methods, false positive predictions have a
larger effect on the determined p-values.
Taking into account that the consensus model graph is less dense as well as
noteably smaller than the TS graph, it performs best in this analysis with an
equal fraction of significantly regulated clusters. However, our results are consis-
tent over all datasets and all different miRNA target site prediction tools.
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4.2.3 Functional relation between host and target genes includes
synergistic as well as antagonistic effects
The previously shown results so far indicate a nondirectional functional relation
between host genes and intronic miRNAs, but do not provide any information
on positive or negative correlations. Since these results show that PT predictions
agree with the two other tools, but due to the small size of the graph and therefore
its lack of robustness, we excluded PT from this analysis.
To test whether one or both of the two proposed functional effects — synergis-
tic or antagonistic — may be identified in our data, we calculated the distance
between the medians of the correlations between the host and predicted tar-
get genes and the correlations between the hosts and randomly sampled targets
(Figure 4.4A and methods). The resulting distances ∆m combined from all three
datasets can be seen in Figure 4.4B and 4.4C. Both distance distributions show
a bimodal distribution with a local minimum at ∆m = 0, but no significant shift
towards a negative or positive correlation. Hence, based on the assumption that
high positive or negative correlation of gene expression patterns indicated similar
or opposite functions, we infer that both proposed effects, knock down and fine
tuning, appear to be equally represented in our data.
Since our investigation is only based on mRNA expression data and further
information on protein levels is missing, the real impact on translation stays
obscure in this analysis. However, in [Baek et al., 2008] it could be shown that
most of miRNA-mRNA interactions function as fine scaling adjustions to the
proteome. Considering the fact that our experimental analysis was only based
on mRNA expression data, only knock down effects are directly visible. But in
agreement with previous work [Selbach et al., 2008], the massive appearance
of positively correlated miRNA and target expression strongly indicates tuning
effects of varying translational repression.
4.2.4 Host and target gene sets display enriched functional similarity
The significantly correlated expression patterns between host genes and miRNA
target genes support the notion that intronic miRNA regulation improves host-
associated biological functions by either tuning or dampening the expression of
target genes. We assume that this relation is also apparent via shared functional
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PT TS C
Hosts targets p targets p targets p
SCD I 9 7 0.0305 275 < 10−4 82 0.1425
SCD II 8 68 0.0578 771 < 10−4 109 < 10−4
SG I 13 149 < 10−4 1521 < 10−4 377 < 10−4
SG II 21 189 < 10−4 1956 < 10−4 486 < 10−4
SG III 7 39 < 10−4 617 0.0008 258 < 10−4
NO I 10 51 0.0016 864 0.0109 112 < 10−4
NO II 17 67 0.0046 1274 < 10−4 218 < 10−4
Table 4.1: Host gene cluster size and number of target genes, predicted with the three
methods Pictar (PT), TargetScan (TS), and our Consensus model (C), respectively.
The p-values determined by a comparison of functional GO similarities between host
and predicted targets to randomly chosen sets of target genes of identical size are shown.
annotations. To test this hypothesis, we determined the commonly used func-
tional similarity of gene products based on Gene Ontology (GO) [Schlicker et al.,
2006] between a single or multiple host genes and their set of target genes. We
then calculated the significance of the mean functional similarity by comparing
the target set with randomly sampled sets of miRNA target genes (see methods).
We analyzed the previously defined clusters SCD I – NO II and calculated
mean functional similarities between the host and target gene sets. Results are
shown in Table 4.1. All host gene clusters display a significantly higher functional
similarity (p < 0.05) to their predicted TS target genes as compared to the null
model of randomly chosen target genes. Only the two clusters SCD I and SCD II
exceed the significance level of 0.05 for consensus model and PicTar predictions,
respectively.
To check whether a high functional similarity can be found for all host-target
relations independent of expression patterns, we additionally calculated the func-
tional similarity score for all host genes and their predicted target gene sets. We
expected the most robust results for the largest network of predicted microRNA
target gene associations, since the score is given by the mean of all host gene -
target gene pairs. In Figure 4.5A, we plotted the frequency distribution of sim-
ilarity scores for TS. We found that the scores are well distributed within the
range of 0 and 5. We compared each similarity score with a null model, where the
same number of target genes is randomly selected from all miRNA target genes
as provided by TS. For the host gene Copz1 for example, we found a significantly
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Figure 4.5: Functional similarity of host and target gene sets as predicted by Tar-
getScan. (A) Frequency distribution of the functional similarity score for all 75 host-
target relations. For each single host gene and its set of target genes, we calculate a mean
score based on the GO annotation ’biological process’. The mean functional similarity
of the host gene Copz1 to its predicted targets is 2.48 (blue line). (B) Comparison of
the real functional similarity score the host gene Copz1 with a null model distribution.
For the null model, a random set of microRNA target genes of the same size has been
chosen 1000 times and the functional similarity score has been calculated. The real score
of Copz1 deviates significantly from the null model distribution, resulting in a high z
score. (C) Z scores for all annotated host genes. A total of 21 out of 75 host genes show
z scores > 2 and thus display a significantly higher functional similarity as expected
from a random sample of target genes.
larger functional similarity to its targets as compared to 1000 randomly selected
sets of microRNA targets (see Figure 4.5B).
For all annotated host genes with available annotations for the respective tar-
gets, we calculated p-values and z scores, as measures of deviation from the null
model. We found that surprisingly many host-target relations deviated from the
null model, with high z scores as can be seen in Figure 4.5C. As many as 57 of all
75 host genes annotated in the ontology ‘biological process’ exhibited a greater
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similarity to their targets (z > 0) than expected by chance, 30 of them with a
p-value < 0.05. For those pairs of host and target genes, a strong correlation
in terms of their annotated ‘biological process’ existed. For the other prediction
tools used on in this study, a similar trend to high z scores could be observed (see
supplementary figure 1). However, these predictions comprise less annotated host
genes (48 and 45 for PicTar and consensus model, respectively) and also about
10 times less links, rendering significant deviations less possible (see methods for
details).
With the use of GO gene annotations we could show that intronic miRNA tend
to target genes that are functionally more similar to the host genes than ran-
domly chosen genes. The strong bias towards positive correlations and absence of
significant dissimilarities agrees with both former proposed regulatory principles
(figure 4.1A,B). Notably, GO terms are not classified on their antagonistic effects
on each other but on biological relations. For instance, two pathways with con-
flicting regulation on a cellular process like ‘cell growth’ are both children of the
parental term and therefore close within the GO tree. Furthermore, two genes
can have opposed regulatory effects on one pathway and would be still grouped
together in the same term.
4.3 Conclusion
The results of this work show that the genomic linkage between intronic miR-
NAs and their host genes coincides with a functional relation. Using a data-
driven as well as a knowledge-based approach, miRNA host genes and related
target genes were analyzed towards functional relations. Expression patterns were
obtained from three developmental datasets. Correlated expressions of host and
miRNA target genes deviated significantly from a random model. Both, positively
and negatively correlation patterns have been observed in approximately equal
amounts. An independent GO analysis of the predicted miRNA-mRNA interac-
tion network confirmed that host and predicted target genes tend be annotated
with similar or related terms, compared to a random model. Taken together,
results indicate for either synergistic or antagonistic regulatory effects mediated
by either downregulation of genes with an opposed function or fine-tuning of
miRNA targets, co-operative to the host gene.
92
4.4 Material and Methods
4.4.1 Microarray data and preprocessing
All analyzed datasets were taken from the GEO [Barrett and Edgar, 2006]
database: (i) The stem cell development (SCD) datasets consists of three cell
lines (R1, J1, V6.5) differentiated into embryoid bodies (EB) at 11 time points
from t=0h until t=d14. From each time point and each cell line 3 technical repli-
cates were measured (combination of three cell line differentiations GSE2972,
GSE3749, GSE3231). (ii) Within the somitogenesis dataset (SG) gene expression
was measured from synchronized C2C12 myoblasts at 13 timepoints from t=0h
until t=6h (GSE7012). (iii) The neurite outgrowth (NO) and regeneration dataset
consists of transcriptional activity, measured from dorsal root ganglia during a
time course of neurite outgrowth in vitro under two conditions: untreated and
under potent inhibitory cue Semaphorin3A. Measurements were taken at 5 time
points from t=2h until t=40h including two technical replicates (GSE9738).
Affymetrix raw data were preprocessed using Bioconductor‘s R package sim-
pleaffy [Wilson and Miller, 2005]. Data was normalized and detection calls were
determined. Expression values were calculated using the RMA algorithm. Each
dataset was filtered independently to remove all probesets with an absent flag in
more then two third of all datapoints within the whole experimental setup.
Gene names and gene symbols for each probeset were derived from the Bio-
conductor Affymetrix Mouse Expression Set 430 annotation data (moe430a.db).
Gene symbols represented by more than one probeset were set to the median
expression values.
4.4.2 Expression profile based analysis
Host gene cluster were defined upon a correlation-based adjacency matrix. For
each microarray dataset we selected all known miRNA host genes and calculated
a correlation matrix based on their expression profiles. Each entry representing
a correlation coefficient above 0.8, was set to 1, all others to 0. This adjacency
matrix now forms a graph of host genes. A host gene cluster was then defined
as a maximal connected subgraph of this graph. This equals nearest neighbour
method applied to hierarchical clustering algorithm with a defined cutoff of 0.8
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of the dendrogramm. For each host gene cluster containing M host genes, the
N corresponding target genes were determined upon the three miRNA target
prediction tools.
We calculated the cluster specific miRNA degree di = #Ti/#Hi where #Ti is
the number of target genes and #Hi the number of host genes of cluster i.
Depending on the respective expression profiles, we calculated the M × N
cross-correlation coefficients between all hosts and all targets. As a null model
we randomly sampled N targets for 500 times. For each sample we calculated all
M × N correlations. Statistically significant differences between the correlation
distributions of our clusters and sampled data were estimated by determining
p-values using Wilcoxon‘s rank sum test.
Distances between the medians of the correlation distributions were calculated
as
∆m = median(Cc)−median(Cs) (4.1)
with Cc being the correlation distribution between the host and the target genes
of one cluster and Cs being the correlation distribution between host genes and
sampled target genes of one cluster.
Hierarchical cluster analysis was performed using Matlab‘s Bioinformatics tool-
box (http://www.mathworks.com) using average linkage with Euclidean distance
metric.
4.4.3 Intronic miRNAs and target prediction
A list of all murine intronic miRNAs and their host genes was downloaded from
the miRBase website (http://microrna.sanger.ac.uk). Predictions made by PT
were downloaded from the UCSC genome browser (http://genome.ucsc.edu) and
TS conserved miRNA target site predictions were downloaded from the TS web-
site (http://www.targetscan.org). Redundant gene to miRNA relationships were
removed from both datasets.
The Consensus model prediction graph used in our analysis was built of five
different miRNA target site prediction tools. Additionally to PT and TS we
used predictions from PITA [Kertesz et al., 2007], Miranda [Betel et al., 2008]
(http://www.microrna.org), and targetspy (Sturm et al, submitted). From all
predictions based on RefSeq transcript IDs, we filtered out only miRNA-transcript
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Figure 4.6: Properties of the three miRNA-target bipartite graphs. (A) The relative
densities, number of existing edges divided by all possible edges, in percent of the three
graphs for Pictar (PT), TargetScan (TS), and consensus model (C). (B) Log-log plot
of number of predicted miRNA targets for all three different prediction graphs. (C)
Log-log plot of cluster specific miRNA target recovery for all three different prediction
graphs (for details see text). (D) The mean of the numbers of predicted miRNA targets
of the complete graphs (grey), and cluster-specific recovery of miRNA targets (orange):
Mean of the sums of all identified targets of one host gene cluster divided by the sums
of all host genes of the cluster.
relations that were predicted by a minimum of four different tools. Transcript
mapping to gene symbols was done using a local copy of the RefSeq database
(September 2008) [Pruitt et al., 2007].
These genome-wide predictions can be represented by a network (bipartite
graph), where the two different sets of nodes are formed by the miRNAs and the
target genes, respectively, and the predicted interactions are formed by the edges.
The three graphs vary primarily in their absolute sizes. PT with 242 miRNAs and
1335 overall predicted targets is very small compared to TS (382 miRNAs, 8879
targets) and consensus model (219 miRNAs, 3249 targets). In figure 4.6A relative
densities for all graphs and in figure 4.6B all degree distributions are shown. For
each cluster a mean miRNA target recovery was calculated as the fraction of the
number of all predicted and recovered target genes of one cluster through the
number of clustered host genes. These distributions again are strikingly similar
whereas the mean still varies strongly (Figure 4.6C,D).
The fraction of the cluster-specific miRNA degree compared to the complete
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graph miRNA degree of consensus model is very high (76%) compared to the
other methods (TS: 50%, PT: 27%). Since TS predicts the highest number of
targets per miRNA, one also expects a relatively huge recovery of target genes
within the dataset. The PT graph is the densest graph of all but also the smallest
one, hence the weak recovery of targets. One reason for the high target recovery
of the consensus model might be that the used prediction tools for the consensus
model score are all trained upon validated data. Therefore, the resulting miRNA-
target predictions contain more training data as the PT and TS, which results
in the high recovery rate.
4.4.4 Functional similarity of host genes and target gene sets
We assume that host genes confer regulatory control by translational inhibition
of the respective intronic microRNA target genes in possibly related biological
processes. To test this hypothesis for all hosts and target genes, we compare
the similarity of their respective annotations. Functional gene annotations as
provided by the GO [Ashburner et al., 2000] classify genes according to their
function, associated biological processes or appearance within defined cellular
components. They are organized hierarchically, typically in a directed acyclic
graph. To each gene more than one classification term can be assigned.
The functional similarity between a host and a target was defined by Resnik’s
measure as described in [Schlicker et al., 2006] and calculated using the Pro-
Cope software suite [Krumsiek et al., 2008]. This method scores relationships
between genes by common appearance within one or more terms or, more ab-
stract, by analyzing their distance within the GO graph. For genes with multiple
term annotations the maximum scoring GO term pair was used. The functional
similarity between a host and a set of targets was determined as the mean of all
single host-target scores. For our study, we downloaded the most recent GO files
and mouse gene annotation lists from the GO website (January, 2009).
In order to assign statistical significance of the functional host-target similar-
ities in our network, we compared the average similarity of each host to all of
its targets against 10.000 randomized networks. To evaluate the host-cluster to
target relations we compared the average host-target similarities in the real net-
work against 10.000 networks with randomized target sets for each host cluster.
We calculated a p-value as the relative number of samples with higher scores.
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The z score was calculated as the deviation of the real score s from the mean m
of the sampled distribution, divided by its standard distribution σ, z = s−m
σ
.
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5 Discussion
The analysis of gene expression is a challenging task in modern biology. Microar-
ray technology allows for large-scale measurements of the expression of thousands
of genes at once. Based on different biological models, various methods have been
developed to analyze these data in an appropriate manner. In this work we dis-
tinguished between mapping and mixing models. Mapping models compare the
expression values of different measurements directly in order to either identify
differentially regulated genes, prevalently appearing expression patterns or to
extract potential marker genes. In contrast, mixing models follow a different ap-
proach. The underlying assumption here is that a single gene expression profile
is composed of several superimposing expression modes. These expression modes
therefore represent specific biological processes responsible for a distinct cellular
task.
The different methods applied range from classical statistic approaches, such as
the t-test, clustering methods like hierarchical clustering, to methods developed
in linear algebra like ICA. In this work two of these methods, ICA and hierar-
chical clustering were applied to different microarray datasets following diverse
biological questions.
In chapter 2 two different classes of gene expression profiles, derived from
monocytes and M-CSF dependent differentiated macrophages, were analyzed.
Statistically independent GEM were extracted from the observed expression pro-
files using ICA. From each GEM a group of genes was deduced, henceforth called
sub-mode. These sub-modes were further analyzed with different database query
and literature mining tools and then combined to form so called meta-modes.
With these a knowledge-based pathway analysis was performed and a well-known
signal cascade could be reconstructed. Although there exists lot of other work
applying ICA to microarray data [Liebermeister, 2002; Lee and Batzoglou, 2003;
Chiappetta et al., 2004], a detailed biological discussion of the results is mostly
missing. In this work, a special focus was to test the ICA derived results for
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biological relevance, and to provide a reasonable approach for interpretation.
The results show that ICA is an appropriate tool to uncover underlying bio-
logical mechanisms from microarray data. Most of the well known pathways of
M-CSF dependent monocyte to macrophage differentiation could be identified
by this unsupervised microarray data analysis. Moreover, recent research re-
sults like the involvement of proliferation associated cellular mechanisms during
macrophage differentiation, could also be corroborated.
Chapter 3, again deals with the application of ICA to microarray data. How-
ever, in contrast to chapter 2 ICA was applied to kinetic gene expression profiles
and compared to the more commonly used method of hierarchical clustering. The
dataset consisted of human monocyte derived macrophages from three different
donors infected with the intracellular pathogen Francisella tularensis.
Results were compared using pathway analysis tools, based on the Gene On-
tology and the MeSH database. It could be shown that both methods lead to
time-dependent gene regulatory patterns, which fit well to known TNFα induced
immune responses. In comparison, the nonexclusive attribute of ICA results in
a more detailed view and a higher resolution in time dependent behavior of the
immune response genes. Additionally, NFκB could be identified as one of the
main regulatory genes during the response to F. tularensis infection.
A less methods and more biology oriented approach applied to microarray
data was discussed in chapter 4. Since up to 53% of mammalian miRNAs appear
to be located within introns of protein coding genes, the linkage between their
expression and the promoter-driven regulation of their host gene was analyzed.
Therefore, the study investigated this linkage towards a relationship beyond tran-
scriptional co-regulation. Using measures based on both annotation and experi-
mental data, it could be shown that host genes and their intronic miRNAs are
often functionally related.
The study showed that miRNA target genes tend to show expression patterns
significantly correlated with the expression of their host genes. By calculating
functional similarities between host and predicted miRNA target genes based on
GO annotations, it could be confirmed that many miRNAs link the annotated
function of their host genes with that of the target genes. Additionally, these
results indicate that miRNAs support host gene activity in an either synergistic
or antagonistic manner.
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The result of the latter analysis also brings a new perception to the analysis
of gene expression data. The so far common paradigm to map these large scale
data to protein associated gene functionality may be extended by the knowledge
of intronic miRNA functionality. This is especially interesting since most com-
monly used microarrays are not only limited to the detection of protein coding
genes, but can also deliver information about further non-coding gene regulatory
mechanisms.
Taken together, this work shows that the analysis of microarray data, depend-
ing on the applied method can lead to diverse biological findings. Thereby, it is
less important to use the most sophisticated tool, but more important to carefully
reflect on the aim of the experiment to choose the appropriate method. However,
developing new analysis tools or assigning methods developed in other fields to
the analysis of large scale gene expression data is still a demanding task. On the
one hand, it is still necessary to overcome open problems like noise reduction
in the data and, on the other hand, to improve the biological outcomes and to
provide more meaningful results.
Furthermore, in some cases a specific tool outperforms a commonly used one as
shown in chapter 3, and should therefore be preferentially used. Hence, newly de-
veloped methods have to be proven carefully in their applicability and compared
to commonly used ones.
Finally, we now will give a short outlook on how to overcome several issues,
improve diverse methods and on future directions in large scale gene expression
data analysis. For instance, investigations on ICA algorithms, including subspace
analysis, will allow for a more adapted mixing model of the underlying biological
processes [Gruber et al., 2009]. Remaining dependencies of extracted biologi-
cal processes may be identified, hence delivering a more adapted view on large
regulatory networks. Further exploration of the mixing coefficients derived with
matrix factorization methods, as described in chapter 3 or in [Schachtner et al.,
2008], from time dependent data may carry out improvements in the reconstruc-
tion of time dependent regulatory networks. A promising idea is the application
of non-negative tensor factorization (NTF) methods [Cichocki et al., 2007], that
allow for the use of higher dimensionality in the mixing model. Thus, varieties
within biological replicates may be identified. For instance, processes running in
different cell lines with different rates may be more precisely reconstructed.
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As the knowledge about miRNAs and the comprehension of their impact on
gene expression grows, the perspective on analyzing mRNA data will certainly
change. Therefore, existing theoretical analysis methods have to be extended and
development of new tools should be conducted with respect to this entity. As ba-
sically presented in this work, the use of graph theoretic approaches and network
representation exhibit a promising approach to future investigations. Using in-
formation from diverse sources, such as microarray analyses, TF and miRNA
regulatory networks, as well as gene annotations, large regulatory networks can
be created. These networks can then be further analyzed and optimized, as for
instance by predicting missing links via applying a Boolean approach. Following
a modern systems biology approach with a high crosstalk between experimental
and theoretical work, will also lead to improvements concerning the biological
relevance of these models. Small subnetworks and motifs will give rise to pointed
experiments that may in turn be used to upgrade the models.
Finally, recently developed experimental methods, like deep sequencing, will
certainly improve the quality of gene expression data. This relatively new open
method allows for large-scale measurements of the transcriptome, independent
of the RNA type and may also deliver information about so far unknown tran-
scripts. However, this technique will also demand new model assumptions and
sophisticated analysis techniques.
In conclusion, we want to point out that the wide field of transcriptome anal-
ysis still offers lots of starting points for new investigatory approaches leading
to further findings that will extend our understanding of the gene regulatory
machinery forming a complete organism out of a single fertilized egg cell.
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A Monocyte/macrophage differentiation
meta-modes
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Table 3 - Signal transduction genes
SYMBOL NAME Pathway CLU ProbeSet
ADAM10 ADAM metallopeptidase domain 10 Cell C. 6.2 214895 S AT
ADM adrenomedullin MAPK 12.2 202912 AT
AIF1 allograft inflammatory factor 1 13.2 209901 X AT
ALDH1A1 aldehyde dehydrogenase 1 family, member A1 12.2 212224 AT
ARF1 ADP-ribosylation factor 1 Cell C. 6.2 208750 S AT
ARFGEF1 ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-
inhibited)
6.2 216266 S AT
ATF3 activating transcription factor 3 MAPK 12.2 202672 S AT
BCL3 B-cell CLL/lymphoma 3 3.2 204908 S AT
BID BH3 interacting domain death agonist 3.2 204493 AT
BIRC1 baculoviral IAP repeat-containing 1 13.2 204860 S AT
BLNK B-cell linker 13.2 207655 S AT
C1QR1 complement component 1, q subcomponent, receptor 1 13.2 202878 S AT
CAMKK2 calcium/calmodulin-dependent protein kinase kinase 2, beta 3.2 212252 AT
CASP1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, conver-
tase)
MAPK 12.2 211368 S AT
CCL3 chemokine (C-C motif) ligand 3 MAPK 12.2 205114 S AT
CD163 CD163 antigen 13.2 215049 X AT
CD36 CD36 antigen (collagen type I receptor, thrombospondin receptor) 13.2 206488 S AT
CD44 CD44 antigen (homing function and Indian blood group system) MAPK 3.2 217523 AT
CD58 CD58 antigen, (lymphocyte function-associated antigen 3) 6.2 216942 S AT
CD83 CD83 antigen (activated B lymphocytes, immunoglobulin superfamily) MAPK 12.2 204440 AT
CD86 CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) 13.2 205686 S AT
CFLAR CASP8 and FADD-like apoptosis regulator Cell C. 6.2 211317 S AT
CSPG2 chondroitin sulfate proteoglycan 2 (versican) 12.2 221731 X AT
CTSK cathepsin K (pycnodysostosis) MAPK 12.2,13.2 202450 S AT
CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity,
alpha)
MAPK 12.2 209774 X AT
CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 3.2,6.2 202435 S AT
DDX3X DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked 6.2 212514 X AT
DUSP1 dual specificity phosphatase 1 MAPK 12.2 201041 S AT
EGR2 early growth response 2 (Krox-20 homolog, Drosophila) MAPK 3.2 205249 AT
EREG epiregulin 3.2 205767 AT
FABP5 fatty acid binding protein 5 (psoriasis-associated) 13.2 202345 S AT
FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) 13.2 214511 X AT
FLI1 Friend leukemia virus integration 1 13.2 204236 AT
G6PD glucose-6-phosphate dehydrogenase MAPK 3.2 202275 AT
GADD45B growth arrest and DNA-damage-inducible, beta MAPK 12.2 209305 S AT
GDI2 GDP dissociation inhibitor 2 Cell C. 6.2 200008 S AT
H2BFS H2B histone family, member S 3.2 209806 AT
HOMER3 homer homolog 3 (Drosophila) Cell C. 6.2 215489 X AT
HPSE heparanase 13.2 219403 S AT
IER3 immediate early response 3 12.2 201631 S AT
IFITM3 interferon induced transmembrane protein 3 (1-8U) 12.2 201315 X AT
IGFBP7 insulin-like growth factor binding protein 7 MAPK 12.2 201163 S AT
IL1RN interleukin 1 receptor antagonist MAPK 3.2 212657 S AT
IL2RG interleukin 2 receptor, gamma (severe combined immunodeficiency) 3.2 204116 AT
IL8 interleukin 8 MAPK 3.2,12.2 202859 X AT
JUNB jun B proto-oncogene MAPK 12.2 201473 AT
KLF10 Kruppel-like factor 10 3.2,12.2 202393 S AT
LMO2 LIM domain only 2 (rhombotin-like 1) 13.2 204249 S AT
M6PR mannose-6-phosphate receptor (cation dependent) 6.2 200900 S AT
MAP3K2 mitogen-activated protein kinase kinase kinase 2 Cell C. 6.2 221695 S AT
MAPK1 mitogen-activated protein kinase 1 MAPK 3.2 208351 S AT
MCP membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive
antigen)
6.2 207549 X AT
MGLL monoglyceride lipase 12.2 211026 S AT
MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV
collagenase)
13.2 203936 S AT
MTSS1 metastasis suppressor 1 13.2 203037 S AT
MYCL1 v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived
(avian)
13.2 214058 AT
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SYMBOL NAME Pathway CLU ProbeSet
NEK3 NIMA (never in mitosis gene a)-related kinase 3 13.2 211089 S AT
NFKBIE nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,
epsilon
3.2 203927 AT
OGT O-linked N-acetylglucosamine (GlcNAc) transferase Cell C. 6.2 207564 X AT
PDE4B phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog,
Drosophila)
12.2 203708 AT
PECAM1 platelet/endothelial cell adhesion molecule (CD31 antigen) 13.2 208981 AT
PLEK pleckstrin 12.2 203471 S AT
PPP1R15A protein phosphatase 1, regulatory (inhibitor) subunit 15A 12.2 37028 AT
PRNP prion protein (p27-30) 6.2 215707 S AT
PSEN1 presenilin 1 (Alzheimer disease 3) Cell C. 6.2 207782 S AT
PTGER2 prostaglandin E receptor 2 (subtype EP2), 53kDa 12.2 206631 AT
PTPRO protein tyrosine phosphatase, receptor type, O 13.2 208121 S AT
RALGDS ral guanine nucleotide dissociation stimulator MAPK 12.2 209050 S AT
RIPK2 receptor-interacting serine-threonine kinase 2 MAPK 12.2 209545 S AT
RPS6KA1 ribosomal protein S6 kinase, 90kDa, polypeptide 1 MAPK 3.2 203379 AT
S100A8 S100 calcium binding protein A8 (calgranulin A) MAPK 12.2 202917 S AT
S100A9 S100 calcium binding protein A9 (calgranulin B) MAPK 12.2 203535 AT
SCAMP1 secretory carrier membrane protein 1 6.2 206668 S AT
SCAP2 src family associated phosphoprotein 2 Cell C. 6.2 216899 S AT
SELL selectin L (lymphocyte adhesion molecule 1) MAPK 12.2 204563 AT
SEPT2 septin 2 6.2 200778 S AT
SH3BP5 SH3-domain binding protein 5 (BTK-associated) MAPK 3.2 201811 X AT
SLA Src-like-adaptor 13.2 203761 AT
SLC3A2 solute carrier family 3 (activators of dibasic and neutral amino acid transport),
member 2
3.2 200924 S AT
SNAP23 synaptosomal-associated protein, 23kDa 6.2 214544 S AT
SOD2 superoxide dismutase 2, mitochondrial MAPK 12.2 215223 S AT
STK17A serine/threonine kinase 17a (apoptosis-inducing) MAPK 3.2 202693 S AT
TALDO1 transaldolase 1 3.2 201463 S AT
TLK1 tousled-like kinase 1 3.2 202606 S AT
TLR4 toll-like receptor 4 Cell C. 6.2,13.2 221060 S AT
TNFAIP3 tumor necrosis factor, alpha-induced protein 3 3.2, 12.2 202644 S AT
TNFAIP6 tumor necrosis factor, alpha-induced protein 6 12.2 206026 S AT
TPP1 tripeptidyl peptidase I 6.2 214196 S AT
TSC22D1 TSC22 domain family, member 1 12.2 215111 S AT
TXN thioredoxin MAPK 3.2 208864 S AT
TXNDC thioredoxin domain containing Cell C. 6.2 208097 S AT
TXNIP thioredoxin interacting protein 6.2,13.2 201008 S AT
TXNRD1 thioredoxin reductase 1 3.2 201266 AT
UCP2 uncoupling protein 2 (mitochondrial, proton carrier) 13.2 208997 S AT
VAMP3 vesicle-associated membrane protein 3 (cellubrevin) 6.2 201337 S AT
YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein,
zeta polypeptide
6.2 200641 S AT
ZNFN1A1 zinc finger protein, subfamily 1A, 1 (Ikaros) 6.2 205039 S AT
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Table 4 - Regulatory sequences genes
SYMBOL NAME Pathway CLU ProbeSet
ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1 4.1 203505 AT
ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1 10.1 204567 S AT
ACAT2 acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase) 11.2 209608 S AT
ADM adrenomedullin TP53 14.1 202912 AT
ALDH1A1 aldehyde dehydrogenase 1 family, member A1 4.1,11.2 212224 AT
ALDH2 aldehyde dehydrogenase 2 family (mitochondrial) 4.1 201425 AT
ALOX5AP arachidonate 5-lipoxygenase-activating protein 10.1 204174 AT
ARTS-1 type 1 tumor necrosis factor receptor shedding aminopeptidase regulator 11.2 210385 S AT
C3AR1 complement component 3a receptor 1 4.1, 14.1 209906 AT
CALR calreticulin 10.1 214315 X AT
CCND2 cyclin D2 JUN/FOS,TP53 10.1, 14.1 200953 S AT
CDC42 cell division cycle 42 (GTP binding protein, 25kDa) TP53 14.1 208727 S AT
CPM carboxypeptidase M 11.2 206100 AT
CREM cAMP responsive element modulator JUN/FOS 10.1 207630 S AT
CTSK cathepsin K (pycnodysostosis) 4.1 202450 S AT
CTSL cathepsin L 14.1 202087 S AT
CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity,
alpha)
JUN/FOS 10.1,14.1 209774 X AT
CXCR4 chemokine (C-X-C motif) receptor 4 4.1 211919 S AT
CYP51A1 cytochrome P450, family 51, subfamily A, polypeptide 1 11.2 216607 S AT
EBP emopamil binding protein (sterol isomerase) 11.2 202735 AT
FBP1 fructose-1,6-bisphosphatase 1 10.1 209696 AT
FDFT1 farnesyl-diphosphate farnesyltransferase 1 11.2 208647 AT
FYB FYN binding protein (FYB-120/130) 4.1 211795 S AT
G0S2 G0/G1switch 2 14.1 213524 S AT
G1P2 interferon, alpha-inducible protein (clone IFI-15K) 4.1 205483 S AT
GADD45A growth arrest and DNA-damage-inducible, alpha JUN/FOS, TP53 10.1, 14.1 203725 AT
GCH1 GTP cyclohydrolase 1 (dopa-responsive dystonia) TP53 14.1 204224 S AT
GGH gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) 11.2 203560 AT
GM2A GM2 ganglioside activator 4.1 212737 AT
HLA-DMB major histocompatibility complex, class II, DM beta 4.1 203932 AT
HLA-DQA2 major histocompatibility complex, class II, DQ alpha 2 4.1, 14.1 212671 S AT
HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 4.1 212998 X AT
HMGCR 3-hydroxy-3-methylglutaryl-Coenzyme A reductase 11.2 202540 S AT
HPSE heparanase 14.1 219403 S AT
HSPA1B heat shock 70kDa protein 1B 11.2 200800 S AT
IER3 immediate early response 3 TP53 14.1 201631 S AT
IL1RN interleukin 1 receptor antagonist JUN/FOS 10.1 212659 S AT
INSIG1 insulin induced gene 1 11.2 201625 S AT
JUN v-jun sarcoma virus 17 oncogene homolog (avian) JUN/FOS 4.1,10.1 201466 S AT
LCP2 lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of
76kDa)
14.1 205269 AT
LDLR low density lipoprotein receptor (familial hypercholesterolemia) 11.2 202068 S AT
LOC440607 Fc-gamma receptor I B2 10.1 214511 X AT
LYZ lysozyme (renal amyloidosis) 11.2, 14.1 213975 S AT
MAPK13 mitogen-activated protein kinase 13 JUN/FOS 10.1 210058 AT
MARCKS myristoylated alanine-rich protein kinase C substrate JUN/FOS 4.1, 14.1 201670 S AT
MMP14 matrix metallopeptidase 14 (membrane-inserted) 10.1 160020 AT
NISCH nischarin 4.1 201591 S AT
NP nucleoside phosphorylase 14.1 201695 S AT
PDGFC platelet derived growth factor C 4.1 218718 AT
PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 14.1 202464 S AT
PHLDA1 pleckstrin homology-like domain, family A, member 1 14.1 217996 AT
PIM1 pim-1 oncogene JUN/FOS, TP53 10.1, 14.1 209193 AT
PLAU plasminogen activator, urokinase JUN/FOS 10.1 211668 S AT
PROCR protein C receptor, endothelial (EPCR) 14.1 203650 AT
PTGS1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cy-
clooxygenase)
11.2 215813 S AT
RALA v-ral simian leukemia viral oncogene homolog A (ras related) 10.1 214435 X AT
RDX radixin 4.1 212397 AT
RPS6KA4 ribosomal protein S6 kinase, 90kDa, polypeptide 4 11.2 204632 AT
S100A12 S100 calcium binding protein A12 (calgranulin C) 14.1 205863 AT
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S100A8 S100 calcium binding protein A8 (calgranulin A) JUN/FOS 10.1 202917 S AT
SHMT2 serine hydroxymethyltransferase 2 (mitochondrial) 10.1 214437 S AT
SLC11A1 solute carrier family 11 (proton-coupled divalent metal ion transporters), mem-
ber 1
10.1 210423 S AT
SOD2 superoxide dismutase 2, mitochondrial JUN/FOS 4.1 215223 S AT
SPINT2 serine peptidase inhibitor, Kunitz type, 2 14.1 210715 S AT
SQLE squalene epoxidase 11.2 209218 AT
TNFAIP6 tumor necrosis factor, alpha-induced protein 6 14.1 206026 S AT
TRAPPC2 trafficking protein particle complex 2 4.1 209751 S AT
TRIB3 tribbles homolog 3 (Drosophila) 14.1 218145 AT
UGCG UDP-glucose ceramide glucosyltransferase 4.1,10.1 204881 S AT
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Table 5 - Differentiation and cell cycle genes
SYMBOL NAME Pathway CLU ProbeSet
AGA aspartylglucosaminidase TP53 11.1 204333 S AT
ALCAM activated leukocyte cell adhesion molecule 12.1 201951 AT
ALOX5 arachidonate 5-lipoxygenase 11.1 204446 S AT
APP amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) TP53 5.2 214953 S AT
ATP1B1 ATPase, Na+/K+ transporting, beta 1 polypeptide 12.1 201242 S AT
CD44 CD44 antigen (homing function and Indian blood group system) TP53 11.1 210916 S AT
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) TP53 11.1 202284 S AT
CSPG2 chondroitin sulfate proteoglycan 2 (versican) TP53 5.2 221731 X AT
CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa 11.1 201533 AT
CYP51A1 cytochrome P450, family 51, subfamily A, polypeptide 1 TP53 12.1 216607 S AT
DUSP6 dual specificity phosphatase 6 TP53 5.2,12.1 208892 S AT
DUT dUTP pyrophosphatase 5.2,11.1 209932 S AT
EIF2AK2 eukaryotic translation initiation factor 2-alpha kinase 2 TP53 5.2 204211 X AT
EPRS glutamyl-prolyl-tRNA synthetase 12.1 200842 S AT
EREG epiregulin 11.1 205767 AT
F8 coagulation factor VIII, procoagulant component (hemophilia A) 5.2 205756 S AT
FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) 5.2 216950 S AT
FCGR3A Fc fragment of IgG, low affinity IIIa, receptor (CD16a) 5.2 204007 AT
FYN FYN oncogene related to SRC, FGR, YES 5.2 210105 S AT
GCLC glutamate-cysteine ligase, catalytic subunit 12.1 202923 S AT
GGH gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) 5.2, 12.1 203560 AT
GSN gelsolin (amyloidosis, Finnish type) TP53 12.1 200696 S AT
HMGB2 high-mobility group box 2 TP53 5.2 208808 S AT
HMGB3 high-mobility group box 3 5.2, 11.1 203744 AT
HMGCR 3-hydroxy-3-methylglutaryl-Coenzyme A reductase TP53 12.1 202540 S AT
IL1RN interleukin 1 receptor antagonist TP53 12.1 212659 S AT
ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 5.2 205885 S AT
LDLR low density lipoprotein receptor (familial hypercholesterolemia) 5.2 202068 S AT
LMNB1 lamin B1 5.2 203276 AT
LYZ lysozyme (renal amyloidosis) 5.2 213975 S AT
MCM5 MCM5 minichromosome maintenance deficient 5, cell division cycle 46 (S.
cerevisiae)
5.2 216237 S AT
NME1 non-metastatic cells 1, protein (NM23A) expressed in TP53 12.1 201577 AT
PCNA proliferating cell nuclear antigen TP53 5.2,12.1 201202 AT
PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) 5.2 212593 S AT
PICALM phosphatidylinositol binding clathrin assembly protein 11.1 212511 AT
PPP1R15A protein phosphatase 1, regulatory (inhibitor) subunit 15A TP53 11.1 37028 AT
PRKCA protein kinase C, alpha TP53 5.2 213093 AT
RRM1 ribonucleotide reductase M1 polypeptide 5.2 201477 S AT
RUNX3 runt-related transcription factor 3 TP53 11.1 204198 S AT
SELL selectin L (lymphocyte adhesion molecule 1) 5.2 204563 AT
SLA Src-like-adaptor 12.1 203761 AT
SLC7A1 solute carrier family 7 (cationic amino acid transporter, y+ system), member
1
12.1 212295 S AT
SMARCA3 SWI/SNF related, matrix associated, actin dependent regulator of chromatin,
subfamily a, member 3
TP53 5.2 202983 AT
SMC4L1 SMC4 structural maintenance of chromosomes 4-like 1 (yeast) 11.1 201664 AT
SOX4 SRY (sex determining region Y)-box 4 11.1 201417 AT
SPTBN1 spectrin, beta, non-erythrocytic 1 5.2 212071 S AT
SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-
dehydrogenase alpha 1)
TP53 11.1 204675 AT
TFDP1 transcription factor Dp-1 5.2 212330 AT
5
Table 6 - Survival/Apoptosis genes
SYMBOL NAME Pathway CLU ProbeSet
ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting
enzyme)
TP53, BAX 13.1 205746 S AT
ALOX5 arachidonate 5-lipoxygenase BAX, FAS 3.1, 9.2 204446 S AT
ALOX5AP arachidonate 5-lipoxygenase-activating protein BAX 3.1 204174 AT
ATF3 activating transcription factor 3 TP53, BAX 8.1 202672 S AT
BAX BCL2-associated X protein TP53 3.1, 8.1,13.1 211833 S AT
BCL2A1 BCL2-related protein A1 4.2 205681 AT
BTG1 B-cell translocation gene 1, anti-proliferative 13.1 200920 S AT
C1QR1 complement component 1, q subcomponent, receptor 1 CALR 4.2 202878 S AT
CACYBP calcyclin binding protein 2.1 210691 S AT
CALR calreticulin 4.2 214315 X AT
CCL3 chemokine (C-C motif) ligand 3 BAX 6.1 8.1 205114 S AT
CCND2 cyclin D2 4.2 200953 S AT
CD36 CD36 antigen (collagen type I receptor, thrombospondin receptor) CALR 4.2 209555 S AT
CD44 CD44 antigen (homing function and Indian blood group system) TP53, FAS 9.2 204490 S AT
CD83 CD83 antigen (activated B lymphocytes, immunoglobulin superfamily) BAX 13.1 204440 AT
CHMP5 chromatin modifying protein 5 2.1 219356 S AT
CSPG2 chondroitin sulfate proteoglycan 2 (versican) TP53, FAS 9.2 221731 X AT
CTSD cathepsin D (lysosomal aspartyl peptidase) TP53, BAX 3.1 200766 AT
CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity,
alpha)
BAX 6.1 8.1 204470 AT
CXCR4 chemokine (C-X-C motif) receptor 4 BAX 3.1,13.1 217028 AT
CYP51A1 cytochrome P450, family 51, subfamily A, polypeptide 1 TP53 2.1 202314 AT
DNM2 dynamin 2 4.2 202253 S AT
DNTTIP2 deoxynucleotidyltransferase, terminal, interacting protein 2 6.1 202776 AT
DUSP1 dual specificity phosphatase 1 TP53, BAX 13.1 201041 S AT
EGR2 early growth response 2 (Krox-20 homolog, Drosophila) BAX 8.1,13.1 205249 AT
EIF5B eukaryotic translation initiation factor 5B TP53 8.1 201027 S AT
ERCC1 excision repair cross-complementing rodent repair deficiency, complementation
group 1
4.2 203719 AT
F8 coagulation factor VIII, procoagulant component (hemophilia A) 9.2 205756 S AT
FAS Fas (TNF receptor superfamily, member 6) TP53 9.2 204780 S AT
FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) 3.1 216950 S AT
FLJ22386 leucine zipper domain protein 13.1 218394 AT
FOXO1A forkhead box O1A (rhabdomyosarcoma) BAX 4.2, 6.1, 13.1 202724 S AT
FYB FYN binding protein (FYB-120/130) BAX 8.1 211795 S AT
FYN FYN oncogene related to SRC, FGR, YES BAX 13.1 210105 S AT
GADD45A growth arrest and DNA-damage-inducible, alpha TP53, BAX 3.1, 6.1 203725 AT
GRB10 growth factor receptor-bound protein 10 9.2 209409 AT
HEBP2 heme binding protein 2 FAS 9.2 203430 AT
HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 TP53 2.1, 3.1, 13.1 213831 AT
IER3 immediate early response 3 P53 6.1 201631 S AT
IGFBP7 insulin-like growth factor binding protein 7 2.1 201163 S AT
IL1RN interleukin 1 receptor antagonist TP53, BAX 8.1,13.1 212659 S AT
ING1 inhibitor of growth family, member 1 TP53, BAX 13.1 208415 X AT
IRS2 insulin receptor substrate 2 BAX 13.1 209185 S AT
ITGAL integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated
antigen 1; alpha polypeptide)
BAX 13.1 213475 S AT
JAG1 jagged 1 (Alagille syndrome) P53 6.1 209099 X AT
LAMP1 lysosomal-associated membrane protein 1 BAX 3.1 201551 S AT
LNK lymphocyte adaptor protein 4.2 203320 AT
LRMP lymphoid-restricted membrane protein 3.1 35974 AT
LY75 lymphocyte antigen 75 FAS 9.2 205668 AT
MAP2K3 mitogen-activated protein kinase kinase 3 4.2 215498 S AT
MAP3K5 mitogen-activated protein kinase kinase kinase 5 6.1 203836 S AT
MCL1 myeloid cell leukemia sequence 1 (BCL2-related) 4.2 200798 X AT
NDUFA5 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa TP53 2.1 201304 AT
NEDD8 neural precursor cell expressed, developmentally down-regulated 8 2.1 201840 AT
NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) TP53, BAX 13.1 207535 S AT
NME1 non-metastatic cells 1, protein (NM23A) expressed in CALR 4.2 201577 AT
OLR1 oxidised low density lipoprotein (lectin-like) receptor 1 13.1 210004 AT
PCBP2 poly(rC) binding protein 2 13.1 213263 S AT
continued on next page
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continued from previous page
SYMBOL NAME Pathway CLU ProbeSet
PCNA proliferating cell nuclear antigen TP53 2.1 201202 AT
PDE4B phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog,
Drosophila)
13.1 203708 AT
PER2 period homolog 2 (Drosophila) 6.1 205251 AT
PLEK pleckstrin 13.1 203470 S AT
PPP1R15A protein phosphatase 1, regulatory (inhibitor) subunit 15A TP53, BAX 13.1 37028 AT
PRKACB protein kinase, cAMP-dependent, catalytic, beta 3.1 202741 AT
PRKCB1 protein kinase C, beta 1 4.2 209685 S AT
PROCR protein C receptor, endothelial (EPCR) CALR 4.2 203650 AT
PSMB8 proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional
peptidase 7)
9.2 209040 S AT
RAD23B RAD23 homolog B (S. cerevisiae) 2.1 201222 S AT
RALGDS ral guanine nucleotide dissociation stimulator FAS 9.2 209050 S AT
REL v-rel reticuloendotheliosis viral oncogene homolog (avian) BAX 13.1 206036 S AT
RNASE2 ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) 9.2 206111 AT
RSL1D1 ribosomal L1 domain containing 1 2.1, 4.2 212018 S AT
S100A8 S100 calcium binding protein A8 (calgranulin A) TP53, FAS 9.2 202917 S AT
S100A9 S100 calcium binding protein A9 (calgranulin B) TP53, FAS 9.2 203535 AT
SERBP1 SERPINE1 mRNA binding protein 1 9.2 210466 S AT
SFRS5 splicing factor, arginine/serine-rich 5 13.1 212266 S AT
SLC11A1 solute carrier family 11 (proton-coupled divalent metal ion transporters), mem-
ber 1
CALR 4.2,9.2 210423 S AT
SOD2 superoxide dismutase 2, mitochondrial TP53 2.1 216841 S AT
SOX4 SRY (sex determining region Y)-box 4 13.1 201417 AT
SPTBN1 spectrin, beta, non-erythrocytic 1 13.1 212071 S AT
STEAP3 STEAP family member 3 9.2 218424 S AT
SUB1 SUB1 homolog (S. cerevisiae) 2.1 214512 S AT
TANK TRAF family member-associated NFKB activator 2.1 209451 AT
TGFB1 transforming growth factor, beta 1 (Camurati-Engelmann disease) TP53, BAX 13.1 203085 S AT
TNFSF10 tumor necrosis factor (ligand) superfamily, member 10 TP53, BAX 2.1, 3.1, 6.1 202688 AT
TNFSF13 tumor necrosis factor (ligand) superfamily, member 13 BAX 3.1 210314 X AT
TRIB3 tribbles homolog 3 (Drosophila) 4.2 218145 AT
UBE1C ubiquitin-activating enzyme E1C (UBA3 homolog, yeast) 2.1 209115 AT
VIL2 villin 2 (ezrin) TP53, FAS 9.2 208623 S AT
WARS tryptophanyl-tRNA synthetase 6.1 200629 AT
7
B Intronic miRNAs
B.1 Intronic miRNAs and host genes
Host Gene miRNA locus
1110001A07Rik mmu-miR-301 intron
2010111I01Rik mmu-miR-24-1 intron
2010209O12Rik mmu-miR-671 exon
2610203C20Rik mmu-miR-125b-1 intron
6230410P16Rik mmu-miR-135a-1 antisense
Aatk mmu-miR-338 intron
Acadvl mmu-miR-324 antisense
Akt1s1 mmu-miR-707 intron
Ank1 mmu-miR-486 intron
Arpp21 mmu-miR-128b intron
Arrb1 mmu-miR-326 intron
Astn1 mmu-miR-488 intron
Atp5b mmu-miR-677 intron
Bcl7c mmu-miR-762 antisense
Calcr mmu-miR-489 intron
Cdkl1 mmu-miR-681 intron
Chm mmu-miR-361 intron
Col27a1 mmu-miR-455 intron
Col7a1 mmu-miR-711 intron
Copz1 mmu-miR-148b intron
Copz2 mmu-miR-152 intron
Ctdsp1 mmu-miR-26b intron
Ctdspl mmu-miR-26a-1 intron
Cutl1 mmu-miR-721 intron
D16H22S680E mmu-miR-185 intron
Dnaja1 mmu-miR-207 intron
Dnm1 mmu-miR-199b antisense
Dnm2 mmu-miR-199a-1 antisense
Dnm3 mmu-miR-199a-2 antisense
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Dnm3os mmu-miR-199a-2 intron
Dusp19 mmu-miR-684-1 antisense
Dvl2 mmu-miR-324 intron
Eda mmu-miR-676 intron
Egfl7 mmu-miR-126 intron
Elmo3 mmu-miR-328 antisense
Evl mmu-miR-342 intron
Ftl1 mmu-miR-692-2 exon
Gabre mmu-miR-452 intron
Gpc1 mmu-miR-149 intron
Gpc3 mmu-miR-717 intron
Grid1 mmu-miR-346 intron
Grik3 mmu-miR-692-2 intron
Grm8 mmu-miR-592 intron
H19 mmu-miR-675 intron/exon
Hnrpk mmu-miR-7-1 intron
Hoxc5 mmu-miR-615 intron
Htr2c mmu-miR-764 intron
Huwe1 mmu-miR-98 intron
Iars2 mmu-miR-215 antisense
Igf2 mmu-miR-483 intron
Inpp5b mmu-miR-698 exon
Irak1 mmu-miR-718 exon
Lpp mmu-miR-28 intron
Map2k4 mmu-miR-744 intron
Mcm7 mmu-miR-25 intron
Mest mmu-miR-335 intron
Mib1 mmu-miR-1-2 antisense
Myh6 mmu-miR-208 intron
Nfyc mmu-miR-30c-1 intron
Nr6a1 mmu-miR-181b-2 antisense
Nrd1 mmu-miR-761 intron
Nupl1 mmu-miR-719 exon
Pank1 mmu-miR-107 intron
Pank3 mmu-miR-103-1 intron
Pde2a mmu-miR-139 intron
Pdia4 mmu-miR-704 exon
Plod3 mmu-miR-702 exon
Ppargc1b mmu-miR-378 intron
Prmt2 mmu-miR-678 exon
Psmb5 mmu-miR-686 exon
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Ptk2 mmu-miR-151 intron
Ptprn2 mmu-miR-153 intron
R3hdm1 mmu-miR-128a intron
Rab11fip5 mmu-miR-705 exon
Rb1 mmu-miR-687 intron
Rcl1 mmu-miR-101b intron
Rfx1 mmu-miR-709 intron
Rnf130 mmu-miR-340 intron
Robo2 mmu-miR-691 intron
Rtl1 mmu-miR-434 antisense
Sf3a3 mmu-miR-697 intron
Sfmbt2 mmu-miR-297b intron
Slit2 mmu-miR-218-1 intron
Slit3 mmu-miR-218-2 intron
Smc4 mmu-miR-16-2 intron
Srebf2 mmu-miR-33 intron
Tln2 mmu-miR-190 intron
Tmem49 mmu-miR-21 3’ UTR/ exon
Trpm1 mmu-miR-211 intron
Trpm3 mmu-miR-204 intron
Ttc28 mmu-miR-701 intron
Ttll10 mmu-miR-429 intron
Wdr82 mmu-let-7g intron
Wnk1 mmu-miR-706 intron
Wwp2 mmu-miR-140 intron
Xpo5 mmu-miR-693 intron
Zc3h7a mmu-miR-689-2 antisense
Zranb2 mmu-miR-186 intron
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B.2 MicroRNA host gene cluster
Each row defines one cluster.
Somitogenesis dataset:
1110001a07rik, Chm, Copz1, Dnm1, Gpc1, Iars2, Mcm7, Nupl1, Pank1, Prmt2,
Sf3a3, Xpo5, Zranb2
2010111i01rik, Calcr, Chm, Ctdsp1, Cutl1, Dnm1, Dnm3, Dnm3os, Dusp19,
Dvl2, Evl, Gabre, Igf2, Mest, Rab11fip5, Rb1, Slit2, Smc4, Srebf2, Ttc28, Wwp2
6230410p16rik, Arrb1, Chm, Elmo3, Htr2c, Irak1, Pde2a
Chm, Psmb5
Ctdspl, Igf2
Dnaja1, Rcl1, Tmem49
Neurite outgrowth dataset:
1110001a07rik, Pank1, Slit2, Ttc28,
Aatk, Bcl7c, Copz2, Ctdsp1, H19, Igf2, Irak1, Lpp, Plod3, Rnf130
Acadvl, Igf2
Astn1, Atp5b, Chm, Copz1, Dnaja1, Dnm1, Evl, Igf2, Map2k4, Nrd1, Nupl1,
Psmb5, Rb1, Rcl1, Sf3a3, Tmem49, Zc3h7a
Stem cell development dataset:
Acadvl, Elmo3, Gpc3, H19, Igf2, Lpp, Plod3, Rab11fip5, Rnf130
Dnaja1, Hnrpk, Igf2, Nfyc, Psmb5, Rcl1, Sf3a3, Xpo5
Igf2, Wnk1
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B.3 Functional similarity
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Figure B.1: Functional similarity of host and target gene sets as predicted by Pictar
and the consensus model. Z scores for all annotated host genes.
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